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ABSTRACT 
 
Reactive oxygen species (ROS) are short-living and highly reactive molecules formed by 
incomplete one-electron reduction of oxygen. Mitochondria produce low levels of ROS as an 
inevitable consequence of oxidative metabolism. Low levels of ROS are normally reduced by non-
enzymatic and enzymatic oxidizing agents, such as glutathione, thioredoxin, superoxide dismutase 
(SOD), catalase and peroxidases. Oxidative stress results from exposure to high levels of ROS, 
which are not detoxified by cellular antioxidizing agents, and produces cellular damage due to the 
oxidation of cellular constituents. ROS, however play not only a damaging role: recent studies have 
demonstrated that they also actively participate in a diverse array of biological processes, including 
normal cell growth, induction and maintenance of the transformed state, and cellular senescence.  
Moreover,  ROS can also provide a signaling function, by acting as an intracellular messenger 
involved in the transduction  of the signaling of cytokines such as TNF-α and IL-1β. We focused 
our attention on the effect of ROS in the activities of two proteins: PKCζ and p66Shc. On the one 
hand, PKCζ is a serine-threonine kinase belonging to the atypical subfamily of PKC proteins. We 
showed that in an in vitro model redox stress induces PKCζ translocation from the cytosol, where it 
is located in resting conditions, to the nucleus. Nuclear PKCζ protects cells from apoptotic stimuli 
such as H2O2  or ceramide and this protective effect is reverted by the selective inhibition of the 
nuclear pool of the protein. The protective effect of nuclear PKCζ is involved in the 
chemoresistance of tumor cells to chemotherapic drugs, as demonstrated by the fact that the 
selective inhibitor of nuclear PKCζ can revert the chemoresistance, suggesting nuclear PKCζ as a 
suitable target in anticancer therapies. On the other hand p66Shc is a Shc protein involved in stress 
responses, in particular it is activated by redox stress and it produces ROS itself. Our purpose is to 
investigate a possible involvement of p66Shc in two different phenomena: autophagy and adipogenic 
transdifferentiation of skeletal muscle cells by comparing  wt mice with p66Shc KO mice. 
Autophagy is a general term referring to pathways for the degradation of cellular constituents 
(cytosol and organelles) by the autophagolysosome; it is activated mainly by nutrient starvation and 
it plays a dual role: it is primarly a surviving mechanism, but it also leads to cell death (called type 
II cell death) thus possibly acting as an alternative to apoptosis. Starting from this notion, and from 
2 
 
the fact that p66Shc KO cells are protected from apoptosis, we investigated a possible role of p66shc 
as a key element in the switch from apoptosis to autophagy. We observed that, while in wt cells 
redox stress induces apoptosis, cells lacking p66Shc in the same condition activate the autophagic 
pathway. We are now trying to investigate the biological effect of these observation. The second 
aspect of our work is the investigation of a putative role of p66Shc in the adipogenic 
transdifferentiation of skeletal muscle precursor cells. To this purpose we used an in vivo model 
and we observed that mice lacking p66Shc exposed to muscle damage (e.g. freeze injury or redox 
stress) show lower adipocyte accumulation than wt mice, thus suggesting a role of p66 in the 
activation of adipogenic differentiation pathway. The key purpose of this work is the evaluation of 
many different effects of ROS production, looking for possible molecular targets to fight 
pathological processes such as chemoresistance and adipogenic degeneration of skeletal muscle. 
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ABSTRACT (ITALIANO) 
 
Le specie reattive dell’ossigeno (ROS) sono piccole molecole altamente reattive e a breve emivita,  
che si formano in seguito alla riduzione incompleta di molecole di ossigeno. Piccole quantità di 
ROS vengono fisiologicamente prodotte a livello del mitocondrio come conseguenza inevitabile del 
metabolismo ossidativo. Bassi livelli di ROS vengono normalmente ridotti da agenti ossidanti, 
enzimatici e non, quali il glutatione, la tioredoxina, la superossido-dismutasi (SOD), la catalasi e la 
perossidasi. Lo stress ossidativo è una condizione derivante dall’esposizione ad elevati livelli di 
ROS, che non vengono completamente eliminati da agenti antiossidanti, e produce danno cellulare 
dovuto all’ossidazione di componenti cellulari. I ROS, tuttavia, non hanno soltanto un effetto 
dannoso: studi recenti, infatti, hanno dimostrato che i ROS partecipano attivamente ad un’ampia 
serie di processi biologici, inclusi la crescita cellulare, l’induzione ed il mantenimento di stati 
trasformati e la senescenza cellulare. Inoltre, i ROS svolgono anche il ruolo di molecole segnale 
agendo come messaggeri intracellulari coinvolti nella trasduzione del segnale di citochine, quali 
TNFa ed IL-1b. Nel presente lavoro, abbiamo focalizzato la nostra attenzione sull’effetto dei ROS 
sulla funzione di due proteine: PKCζ e p66Shc. PKCζ è una serin-treonin chinasi appartenente alla 
sottofamiglia delle PKC atipiche. Abbiamo dimostrato che, in vitro, uno stress redox induce la 
traslocazione di PKCζ dal citosol, dove è localizzata in condizioni di riposo, al nucleo. La porzione 
di PKCζ nucleare protegge le cellule dagli effetti apoptotici di vari stimoli, quali alte concentrazioni 
di H2O2 o ceramide, e questo effetto protettivo viene annullato dall’inibizione selettiva della 
porzione nucleare di PKCζ. L’effetto protettivo di PKCζ, inoltre, risulta essere coinvolto nello 
sviluppo di chemoresistenza da parte di cellule tumorali, come dimostrato dal fatto che l’inibizione 
selettiva della porzione nucleare della chinasi può ridurre questo fenomeno, suggerendo che PKCζ 
potrebbe rappresentare un possibile target nello sviluppo di farmaci coadiuvanti terapie 
antitumorali. p66, invece, è una proteina adattatrice appartenente alla famiglia delle proteine Shc ed 
è coinvolta nella risposta cellulare a stress ossidativi; in particolare p66 viene attivata in seguito ad 
uno stress redox e, quando attivata, può agire da ossido reduttasi mitocondriale producendo ROS. Il 
nostro principale scopo nel presente lavoro, è stato quello di analizzare un possibile ruolo di p66 in 
due diversi fenomeni: l’autofagia e il differenziamento adipocitario di precursori miogenici, 
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attraverso la comparazione di topi wt e di topi KO per p66. Il termine autofagia fa riferimento ad un 
meccanismo di degradazione di componenti cellulari (citosol ed organelli), da parte di strutture 
digestive dette autofagolisosomi. L’autofagia viene attivata principalmente in seguito alla 
deprivazione di nutrienti e svolge principalmente due ruoli: da una parte, infatti, agisce come 
meccanismo di sopravvivenza in condizioni metaboliche avverse, d’altro canto può culminare nella 
morte cellulare (è conosciuta come morte cellulare di tipo II), agendo in questo modo come 
meccanismo alternativo rispetto all’apoptosi. Partendo da questa nozione, nonché dal fatto che 
cellule KO per p66 sono protette dall’apoptosi, abbiamo analizzato un possibile ruolo di p66 come 
elemento chiave nello swith fra apoptosi ed autofagia. Abbiamo osservato che, mentre in cellule wt, 
uno stress redox induce apoptosi, cellule p66KO nelle stesse condizioni attivano la via autofagica; 
stiamo adesso cercando di comprendere l’effetto biologico di queste osservazioni. Il secondo 
aspetto del nostro lavoro consiste nell’analisi di un possibile ruolo di p66 nel differenziamento 
adipocitario di precursori miogenici localizzati a livello del muscolo scheletrico. A tale scopo 
abbiamo utilizzato un modello in vivo ed abbiamo osservato che topi privi di p66 in seguito ad un 
danno muscolare (indotto, per esempio, in seguito a freeze-injury o ad uno stress redox), presentano 
un minor accumulo di adipociti rispetto ai wt, suggerendo un ruolo di p66  nell’attivazione di vie di 
differenziamento adipogenico. Lo scopo principale di questo lavoro è stata la valutazione di alcuni 
dei diversi effetti dovuti alla produzione di ROS, attraverso l’analisi di possibili target molecolari 
utili per intervenire in processi patologici quali la resistenza a farmaci chemioterapici e la 
degenerazione grassa del tessuto muscolare scheletrico in cui lo stress ossidativo sembra svolgere 
un ruolo di primo piano. 
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INTRODUCTION 
 
REACTIVE OXYGEN SPECIES 
 
Reactive oxygen species (ROS) are defined as molecules or ions formed by the incomplete one-
electron reduction of oxygen. There are two types of ROS: free radicals, which contains one or 
more unpaired electron in their external molecular orbital, such as superoxide (O2-) or hydroxyl 
radicals (HOO-), and non radical species, such as hydrogen peroxide (H2O2). ROS are produced by 
the cells during their normal metabolism and the major source of ROS are mitochondria, in 
particular the respiratory chain.  The respiratory chain, located in the inner mitochondrial 
membrane, is composed of four multimeric integral membrane protein complexes (I-IV), coenzyme 
Q and cytochrome c (cyt c) , a peripheral protein that binds to the outer surface of the inner 
membrane. The respiratory chain complexes I and III are the primary mitochondrial sources of 
univalent reduction of O2 into superoxide. Superoxide can be rapidly converted into H2O2 by 
superoxide dismutase (SOD); two different SOD isoforms exist in the cell: CuZnSOD, that resides 
in the mitochondrial intermembrane space and in the cytosol and needs Cu or Zn as cofactors, and 
MnSOD, which is localized in the mitochondrial matrix and needs Mn as cofactor. Once generated, 
uncharged H2O2 moves across mitochondrial membranes into the cytosol, where it can be converted 
to water by catalase or glutathione peroxidase. Otherwise, in presence of transition metals (such as 
Fe2+), H2O2 can be converted to hydroxyl radicals (OH-), which are highly reactive.  Other sources 
of free radicals are the endoplasmic reticulum system, the  NADPH oxidase complex and the nitric 
oxide synthase (NOS), which produces nitric oxide (NO.) from arginine. NO. is reactive a radical 
having a very short half-life, which can react with superoxide to form peroxynitrite (ONOO-), a non 
radical species, which is capable of modifying the structure and function of proteins.  In 
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physiological conditions cells employ a number of mechanisms to scavenge and detoxifie ROS to 
maintain a permissive redox environment. The glutathione redox couple (GSH/GSSG) is the 
primary cellular redox buffer: GSH is cysteine containing tripeptide that can directly scavenge ROS 
or act as a cofactor for glutathione peroxidase. GSH is subsequently reduced by glutathione 
reductase which uses NADPH as a substrate. NADH/NAD+ couple also play a role in redox 
buffering, as thioredoxin, a disulphide containing protein that can directly scavenge H2O2 as part of 
thioredoxin reductase and thioredoxin peroxidase system. ROS detoxification also involves 
enzymes such as SOD, which catalyzes the dismutation of O2- into H2O2 and O2, and catalase, 
which detoxifies H2O2. ROS are chemically reactive molecules that play both toxic and essential 
functions in living organisms. A moderate increase in ROS can promote cell proliferation and 
differentiation, through the regulation of the activity of enzymes such as ribonucleotide reductase, 
they can mediate inflammation by stimulating cytokine production and they can eliminate 
pathogens and foreign particles. On the other hand, excessive amount of ROS (condition known as 
redox stress or oxidative stress) can cause damage to the cells. Many components of cells can be 
target for ROS-induced oxidation: DNA, in presence of excessive ROS levels, undergoes oxidative 
damage, which can be assessed by analyzing the levels of 8-hydroxideoxoguanosine which 
accumulates in DNA; mitochondrial DNA (mtDNA) is particularly susceptible to oxidative 
damage, probably because it is closer to the site of ROS generation. ROS can also produce 
oxidative damage to proteins and lipids. Lipid peroxidation consists of the interaction of OH. 
radical with unsaturated bonds in a membrane lipid and it affects membrane permeability and 
function. Therefore, maintaining ROS homeostasis is crucial for normal cell growth and survival, 
for this reason cells finely control the balancing of ROS generation and scavenging. An increase in 
ROS, indeed, is associated with many pathological states, such as abnormal cancer cell growth and 
diabetes. 
Compared with normal cells, malignant cells seem to function with higher levels of endogenous 
oxidative stress in culture and in vivo (Szatrowski and Nathan 1991; Kawanishi and Murata 2006). 
For example, leukemic cells freshly isolated from blood samples  show increased ROS production 
compared with normal lymphocytes (Zhou, McEarchern et al. 2003; Kamiguti, Serrander et al. 
2005), while in solid tumors oxidized DNA bases and lipid peroxidation products have been 
observed ((Patel, Rawal et al. 2007; Kumar, Koul et al. 2008). Moreover, malignant cells show an 
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alteration in the regulation of redox homeostasis due to a reduction in the activity of ROS-
scavenging enzymes.  The precise pathway leading to redox stress in cancer cells  remains yet 
unclear, but many intrinsic and extrinsic pathways are thought to be involved in oxidative stress 
during cancer development. Some examples of intrinsic factors are represented by the activation of 
oncogenes (such as those associated with tumor transformation like Ras, Bcr-Abl, c-Myc), by the 
aberrant metabolism, by mitochondrial dysfunctions and by the loss of functional p53. 
Mitochondrial DNA (mtDNA) mutations have also been shown to be correlated with increased 
ROS levels in certain types of cancer cells, because several protein components of the electron 
transport chain are encoded by mtDNA, so mutations of these genes cause impairment in electron 
transfer, leading to leakage of electrons and generation of superoxide. At an advanced disease stage, 
redox stress becomes part of a vicious cycle, in which ROS induce gene mutations, thus leading to 
further metabolic dysfunction and ROS generation. Moreover, in physiological conditions, p53 acts 
as a transcription factor which regulates, among the others, the expression of genes involved in the 
regulation of the redox state. One of the most common feature of cancer cells is the loss of function 
of p53, which produces redox imbalance, high mutagenesis and aggressive tumor growth. Extrinsic 
mechanism leading redox stress in cancer cells are due to the interaction of cancer cells with the 
microenvironment: examples of extrinsic factors are represented by the presence of inflammatory 
cytokines, such as TNFα, by macrophages, by an imbalance of nutrients and by the presence of an 
hypoxic environment. Increased ROS stress in cancer cells correlates with the aggressiveness of 
tumor and with poor prognosis and this aspect is in apparent contradiction with the proapoptotic 
effect of ROS which should, on the contrary, promote the elimination of cancer cells. This 
contradiction can be explained by the fact that it has been observed that cancer cells can survive 
oxidative stress thanks to the acquirement of adaptive mechanisms consisting of an increased ROS 
scavenging activity. During malignant transformation, therefore, oncogenic signals both induce 
ROS generation to stimulate cell proliferation through redox-sensitive transcriptional factors, and 
promote antioxidant adaptive mechanisms to minimize oxidative damage.  All of these mechanisms 
also confer to cancer cells an increased capacity to tolerate exogenous stress and insults, so they are 
involved in the development of drug resistance which is one of the main characteristic of cancer. 
An increase in ROS production can also influence the viability of cells: dependent on the impact of 
ROS, the cells can either repair the damage or activate pathways leading cellular suicide through 
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apoptosis, a form of cell death that occurs during several pathological situations in multicellular 
organisms, characterized by cell shrinkage, chromatin condensation DNA fragmentation and 
formation of “apoptotic bodies”. The execution of the apoptotic program consists mainly in the 
activation of the caspase cascade. Caspases are cysteine-containing, aspartic-acid specific proteases 
which exist as  zymogens in the soluble cytoplasm, mitochondrial intermembrane space and nuclear 
matrix of all cells. The cascade of caspases ends in the cleavage of many protein targets, for 
example endonucleases which, once activated, enter the nucleus and are responsible for DNA 
fragmentation. Many studies investigated the role of redox stress in the regulation of apoptosis, 
underlying an apparent contradictory effect of ROS. Indeed, incubating cells with exogenous 
oxidants or adding redox-active compounds triggers apoptosis, but the mechanism is not yet 
completely clear. One possibility is that ROS produce a damage which, when sensed by the cell, 
activate the apoptotic machinery; one example is the detection of DNA damage by p53. One other 
explanation is that ROS, at low concentration, can activate caspases thus inducing apoptosis, but the 
most important mechanism leading ROS-induced apoptosis is the impairment of mitochondrial 
function. ROS indeed seem to be involved in the mitochondrial permeability transition (MPT), in 
particular they increase the efflux of mitochondrial Ca2+ through the MPT and the efflux of Ca2+ 
disrupts the ion homeostasis and causes drastic changes in mitochondrial ultrastructure and 
functional activity. MPT results in mitochondrial failure which can lead to necrosis due to ATP 
depletion, or, if MPT occurs in a subpopulation of mitochondria and the remaining  organelle can 
maintain membrane potential and produce enough ATP,  to caspase activation and apoptotic 
program. Finally, ROS can induce apoptosis by leading the release of cytochrome C from 
mitochondrial intermembrane space. Cytochrome c, indeed, is normally bound to the inner 
mitochondrial membrane, associated with the anionic phospholipid cardiolipin: the binding of 
cytochrome c with cardiolipin is fundamental to maintain cytochrome c into mitochondria. ROS 
induces cardiolipin oxidation, thus decreasing its binding affinity for cytochrome c, which, after the 
outer mitochondrial membrane permeabilization, can be released into the cytosol, where it binds to 
Apaf1 thus forming the so-called apoptosome, which recruits and binds the procaspase 9, which, 
when activated, starts the apoptotic program. 
Oxidative stress moreover, both is affected by and affects autophagy, a process by which eukaryotic 
cells degrade and recycle macromolecules and organelles. First of all, autophagy is involved in the 
9 
 
clearance of damaged mitochondria, thus decreasing their potential oxidative damage; this process, 
named mitophagy, plays an important role in protecting cells from ROS-induced cell death. 
Moreover, oxidized substrate proteins can be eliminated through chaperone-mediated autophagy 
and they can translocate to lysosomes more efficiently than their unaltered counterparts. ROS, in 
particular mitochondrial ROS, might also have a signaling role in autophagy, as demonstrated by 
many evidences collected so far. For example, it has been demonstrated that TNF-α, induces 
accumulation of H2O2 through the inhibition of mitochondrial electron transfer, thus inducing the 
expression of Beclin-1 and leading to autophagic cell death. (Djavaheri-Mergny, Amelotti et al. 
2006). Moreover, rapamycin in yeast and NGF-deprivation in neurons lead to lipid peroxidation, 
which in turn activates autophagic cell death (Kirkland, Adibhatla et al. 2002; Kissova, Deffieu et 
al. 2006). Nutrient starvation, moreover, induces an accumulation of H2O2, probably through 
phosphoinositide III kinase (PI3K), H2O2 oxidizes Atg4, a protease which activation is necessary 
for autophagosome formations (Scherz-Shouval, Shvets et al. 2007), thus inducing autophagy.
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AUTOPHAGY 
 
The term “autophagy” literally means “self-eating” and it refers to an highly conserved process in 
eukaryotes by which long-lived cytosol proteins and organelles are delivered to lysosomes for bulk 
degradation. This process allows the elimination of damaged, aberrant or aggregated proteins, thus 
protecting cells from their potential damaging effects. At least, three different types of autophagy 
have been described. The most extensively characterized is macroautophagy, in which portions of 
cytosol and entire organelles are engulfed by double-membrane structures called autophagosome, 
which then fuse which lysosomes, thus forming a single-membrane structure called 
autophagolysosome, in which luminal content is degraded and resulting elements (in particular 
macromolecules necessary to sustain cell metabolism) return into the cytosol for cell reactions 
(Klionsky and Emr 2000). The regulation of macroautophagy is complex and it is not yet 
completely clear. Its major negative regulator is the mammalian Target Of Rapamycin (mTOR), 
which inhibits the formation of autophagosomes:  mTOR acts mainly as an aminoacid sensor and in 
nutrient starvation conditions, when the availability of aminoacids decreases, it is inhibited thus 
triggering autophagy . The same effect can be induced by rapamycin itself, a chemical inhibitor of 
mTOR. In my work I will focus my attention in particular on macroautophagy, so I will refer to it 
simply as autophagy. The second type of self-eating is microautophagy, in which the engulfment is 
made directly by the lysosomal membrane; differently from macroautophagy, microautophagy is 
not activated by nutrient deprivation. One particular type of microautophagy is micropexophagy, 
the highly selective degradation of peroxisomes described in yeast as crucial in response to 
oxidative stress. The third type of self-eating is chaperone-mediated autophagy (CMA), in which 
cytosolic proteins showing a specific pentapeptide lysosomes-targeting motif (the consensus 
sequence KFERQ) are recognized by a complex of chaperone proteins and targeted to lysosomal 
membrane, where they bind to the lysosome-associated membrane protein LAMP2a. Substrate 
proteins are then unfolded and transported to the lysosomal lumen for degradation . One example of 
protein degraded through this pathway is represented by the amyloid β precursor protein (APP).  
Autophagy was morphologically first identified in 1960s in mammalian cells, however the 
molecular machinery regulating this process has not yet been completely elucidated. More than 20 
genes, named autophagy-related genes (ATG) involved in the regulation of this process have been 
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identified both in yeast and in mammals. Autophagy occurs at a basal level in normal growing 
conditions, however certain types of environmental stress (such as nutrient starvation) result in a 
dramatic induction.  Autophagy mainly consists in a membrane-trafficking process in which a large 
number of cytoplasmic components are non-selectively enclosed within a double-membrane 
structure named autophagosome and delivered to the vacuole-lysosome for degradation and 
recycling. The biogenesis and consumption of autophagosomes can be divided into four steps: 1) 
induction of vesicle formation mainly by nutrient deprivation; 2) engulfment of the selected cargo 
by a membrane and fusion of the extremities of the surrounding membrane to generate a double-
membrane vesicle; 3) fusion of the autophagosome with the vacuole in yeast or with the lysosome 
in mammals (this process is mediated by a fusion machinery similar to the one used by Golgi and 
endosome-derived vescicles to fuse with vacuoles, including SNARE proteins, a RAB-GTPase and 
a class C vps complex); 4) vesicle breakdown, consisting in the release of the inner vesicle (called 
autophagic body) into the vacuolar or lysosomal lumen. Each step of this process is finely regulated 
by specific proteins; the fundamental step allowing the correct execution of the autophagic process 
is the closure of autophagosome. In this step the protein Atg8 and its mammalian ortologues, LC3, 
GATE16 and GABARAP, play a key role. Atg8/LC3 is an ubiquitin-like protein and it is produced 
in an inactive form which serves as a substrate for the cysteine protease Atg4, which cleaves its 
substrate thus exposing a glycine residue at its C-terminus. This form of Atg8/LC3, named form I, 
is unconjugated and soluble and it diffuses throughout the cytosol. During autophagy, form-I 
Atg8/LC3 becomes phosphatidyletanolamine (PE)-conjugated and membrane-bound, thus 
producing form-II which is bound to the autophagosome membrane. This process is catalyzed by an 
ubiquitination-like reaction performed by an E1-like enzyme, Atg7, and an E2-like enzyme, Atg3 
(Hanada, Satomi et al. 2009). Many studies demonstrated that a defect in LC3 function or activation 
leads to the failure of autophagosome closure, thus underlying a central role of Atg8/LC3 in the 
correct formation of autophagosomes (Fujita, Hayashi-Nishino et al. 2008; Sou, Waguri et al. 
2008). The translocation of the protein Atg8/LC3 from cytosol to autophagosomal membranes 
following autophagy induction is largely implied for the study of the apoptotic process: a fusion 
protein of LC3 with a fluorescent protein (GFP or YFP), indeed, allows to visualize the localization 
of the protein: in resting condition, LC3 is diffused in the cytosol, while upon starvation it shows a 
punctuate localization, due to its incorporation in the membrane of the forming vesicles. 
12 
 
  
Fig. 1: Schematic representation of autophagosome formation and of post-transcriptional LC3 modifications 
  
 
The protein TOR is one of the most important regulators of the autophagic process. The protein was 
originally identified by genetic screens in S.cerevisiae and subsequently in other organisms 
including fungi, mammals, flies and worms (Crespo and Hall 2002; Crespo, Diaz-Troya et al. 
2005). TOR is present ad a single gene in most eukaryotes, but some organisms, like yeast and 
fungi, show two TOR genes. The TOR kinases are large (about 270kDa) proteins that assemble into 
two structurally and functionally distinct complexes termed TORC1 and TORC2. In yeast TORC1 
contains either TOR1 or TOR2, KOG1, TGO89 and LST8, whether TORC2 includes TOR2, LST8, 
BIT61, AVO1 and AVO3; mammalian TOR (mTOR), similarly, associates with raptor (homologue 
of KOG1) and mLST8 to form mTORC1, while it associates with mLST8, rictor and SIN1 
(homologues respectively of AVO3 and AVO1) to constitute mTORC2. The complex mTORC1 is 
sensitive to the inhibitory effect of rapamycin: rapamycin, indeed, after forming a complex with 
FKBP12, can inhibit the proper interaction between mTOR and raptor. This complex is involved in 
the regulation of cell growth and, under favorable growth conditions it is active and it promotes 
ribosome biogenesis and initiation of the translation by inducing the phosphorylation of the protein 
S6 kinase (S6K) (Hara, Maruki et al. 2002). The TORC1 complex is a master controller of protein 
synthesis integrating signals from growth factors and nutrient conditions of the cell. TORC1, 
indeed, regulates protein synthesis by directly phosphorylating 4E binding protein 1 (4EBP1) and 
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p70S6K (S6K) translation initiation factors which are important to mRNA translation, thus 
increasing the level of proteins involved in proliferation, cycle progression and survival pathway. 
Moreover, TORC1 acts as an aminoacid sensor and regulates the autophagic process. TORC2, 
otherwise, regulates cell growth in a rapamycin-insensitive manner; in particular it is involved in 
the control of cell polarity through the regulation of actin cytoskeleton polarization. I will focus my 
attention on the complex TORC1, being it involved in the regulation of autophagy. In particular, 
TORC1 acts as a negative regulator of autophagy by sensing environmental change, in particular, it 
acts as a sensor for a variety of upstream signals, like growth factors, insulin, aminoacids such as 
leucine and glutamine, and intracellular levels of ATP, phosphatidic acid, and inorganic 
polyphosphates . In mammalian cells, mTOR is regulated by pathway PI3K-Akt, in particular it has 
been shown that Akt indirectly stimulates TORC1 activity (Sekulic, Hudson et al. 2000). 
It has been observed that mTOR regulates autophagy by controlling the phosphorylation state of 
Atg13: in nutrient-rich conditions Atg13 is highly phosphorylated and it shows a low affinity for 
Atg1, thus repressing autophagy; under starvation conditions or following a rapamycin treatment, 
mTOR is inhibited and Atg13 is partially and rapidly dephosphorylated and it interacts with Atg1 
with an high affinity. Once the complex Atg13-Atg1 is formed, it interacts with multiple proteins, 
such as Vac8, Atg11 and Atg17 (Hosokawa, Hara et al. 2009). The formation of this multiproteic 
complex plays an important role in the regulation of the autophagosome biogenesis.  
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APOPTOSIS 
 
Apoptosis (also known as programmed cell death) is a physiological process used to eliminate 
superfluous, damaged, infected or aged cells in multicellular organisms. Apoptosis is an highly 
orchestrated program of cell removal necessary to the organism in many contexts, like immune 
response, infection or elimination of DNA damage, because it minimizes the damage to 
surrounding viable tissues. During apoptosis, indeed, the cellular architecture is dismantled in an 
highly controlled way and apoptotic cells show a series of typical morphological features, like 
chromatin condensation, phosphatidylserine exposure, mitochondrial fragmentation (due to the 
action of Drp1, which oligomerizes around mitochondria and induces their fission in a GTP-
dependent manner) membrane blebbing and cell shrinkage, which leads to the fragmentation of the 
cell into small vesicular bodies which can be taken up by macrophages. The apoptotic process is 
complex and finely regulated, and its dysregulation can lead to many diseases like 
neurodegeneration, autoimmunity and cancer. In particular, while uncontrolled proliferation and 
reduced sensitivity to apoptotic signals are classic hallmarks of oncogenic transformation, excessive 
and inappropriate apoptosis is the basis of neurodegenerative diseases like Alzheimer disease. 
Molecularly, the execution of the apoptotic program, is due to a family of cysteine proteases called 
caspases (cysteine aspartic-specific proteases), that cleave substrates at the N-terminal side of a 
specific aspartic-acid residue. Caspases are synthesized as inactive zymogens (procaspases), that 
require proteolytical cleavage to form the large and small subunits of the active enzyme; the 
activation can happen through autoproteolysis or by other activated caspases. Apoptosis in 
mammals can be initiated through two different pathways: the extrinsic pathway involves 
extracellular ligands, while the intracellular pathway involves the release of molecules from 
mitochondria intermembrane space. In both cases, the apoptotic program is a two step proteolytical 
pathway: the first step consists of the activation of “initiator caspases”  (caspase 9 and caspase 8), 
while the second step consists in the activation of “executioner caspases” (caspase 3 and caspase 7), 
that cleave a number of cellular proteins to drive forward the biochemical events that culminate in 
death and dismantling of the cell. Some example of classical downstream target of executioner 
caspases are: the fibrous protein of nuclear lamin, which cleavage alters the nuclear characteristic of 
nuclear envelop, ICAD/DFF45, which cleavage determines DNA fragmentation, p21 kinase and 
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PARP. As just said, apoptosis can be triggered through two different pathways. The extrinsic 
pathway is activated by extracellular molecules binding to the Fas/APO-1 transmembrane protein, 
which is a member of the tumor necrosis factor receptor (TNFR): when Fas/APO1 binds to its 
receptor, it induces the recruitment of procaspase 8 thanks to the adaptor protein FADD (Fas-
associated death domain-containing protein). Upon recruitment to the receptor complex, caspase 8 
becomes activated through autoproteolysis and subsequently cleaves and activate caspase-3. On the 
other end, in the intrinsic pathway, a central role is played by mitochondria. The central event in 
this case, indeed, is the mitochondrial outer membrane permeabilization (MOMP), which allows the 
escape of proapoptotic molecules from mitochondria, including the second mitochondria-derived 
activator of caspase (Smac, also known as Diablo) and cytochrome c. In particular, the intrinsic 
pathway is activated by cellular stresses such as DNA damage, heat shock, oxidative stress and 
many other forms of cellular damage, which result in caspase activation through the release of 
cytochrome c from mitochondria following MOMP and the subsequent formation of the 
apoptosome, a large caspase activating complex, composed of seven Apaf-1 subunits binding 
cytochrome c, dATP and procaspase 9. Apaf1 is the mammalian homologue of Ced4 and it consists 
of three functional domains: an N-terminal CARD (caspase-recruitment domain), a central 
nucleotide-binding domain and a twelve to thirteen WD40 repeats at the C-terminus of the 
molecule. In the absence of an apoptotic stimulus, Apaf1 exists in a monomeric form and the 
WD40-repeat region maintains it in an autoinhibited state. When an apoptotic stimulus activates the 
intrinsic pathway, cytochrome c is released from mitochondria and it binds to the WD40-repeat 
region of Apaf1. When Apaf1 binds cytochrome c, the autoinhibition is removed and the dATP 
bound to the nucleotide binding site is hydrolyzed to dADP. In this form Apaf1 can oligomerize, 
thus forming a seven-member ring acting as a recruitment platform for procaspase9 , which is 
activated, thus starting the proteolytical apoptotic cascade. Interestingly, inside mitochondria 
cytochrome c is present in two different location: a minor pool is free in inter-membrane space, and 
a major pool is enclosed in cristae (Delivani and Martin 2006). The release of cytochrome c after 
MOMP is performed in two following steps: first the soluble pool and then the pool present in 
cristae (Scorrano, Ashiya et al. 2002). The opening of cristae junction plays a key role in apoptosis 
because in some cell types the soluble cytochrome c is not sufficient to induce the formation of the 
apoptosome. The morphology of cristae junction and their opening during apoptosis are regulated 
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by Opa1, a large GTPase also involved in the inner mitochondrial membrane opening (Frezza, 
Cipolat et al. 2006).  
The mitochondrial pathway (also known as intrinsic pathway) of apoptosis is regulated by members 
of the Bcl2 family proteins. The Bcl2 gene was originally identified as a proto-oncogene involved 
in the translocation of human follicular lymphoma (Tsujimoto, Ikegaki et al. 1987) and, in contrast 
to many oncogenes it does not trigger cell proliferation but it promotes cell survival  under negative 
conditions. Bcl2 is the prototype of a large family of proteins which share a large degree of 
homology although they exert many different functions: in particular some of them play an anti-
apoptotic role, while some other proteins act as proapoptotic mediators. Anti-apoptotic proteins, 
like Bcl2, BclxL, BclW and Mcl1, have usually four Bcl2 homology (BH) domains, while 
proapoptotic proteins display either three BH  domains (BH1, BH2 and BH3), like Bax and Bak, or 
only the BH3 domain, like Bid, Bim and Bad, Noxa and Puma.  Anti-apoptotic Bcl2 protein acts by 
binding and sequestering proapoptotic proteins, including activator BH3-only proteins, but this is 
not their only mechanism. Our group indeed, showed that Bcl2 is also involved in the regulation of 
Ca2+ homeostasis, in particular it induces Ca2+ depletion from endoplasmic reticulum, thus avoiding 
the Ca2+ overload to mitochondria, and the following MOMP (Pinton, Ferrari et al. 2001).  On the 
other hand, Bax and Bak directly participate in the formation of pores in the outer mitochondrial 
membrane (Chami, Prandini et al. 2004). In healthy cells Bax is located in the cytosol, with a minor 
pool loosely attached to mitochondria. Upon several apoptotic stimuli, BH3 only proteins like Bim 
and Bid  induce a conformational change in its structure which targets it to the MOM. When it is 
located to the MOM, Bax can oligomerize, thus forming pores and determining MOMP (Schafer, 
Quispe et al. 2009). Bak, instead, is constitutively inserted in the MOM, where it is bound to and 
inhibited by VDAC2, BclxL and Mcl1 (Cheng, Sheiko et al. 2003; Willis, Chen et al. 2005). Bax  
oligomerization, otherwise, requires BH3 only proteins to induce MOMP (Korsmeyer, Wei et al. 
2000).  Finally, BH3 only proteins can be divided into two classes: on one hand “activator BH3 
only proteins” can directly bind to Bax and Bak and recruit them to the MOM, for example Bid, 
Bim, Map1 and Puma exert this function; on the other hand, “sensitizers BH3only proteins” act by 
competitively inhibiting the anti-apoptotic members of the Bcl2 members, for example Bad 
selectively binds Bcl2 and BclxL, while Noxa specifically binds Mcl-1 (Fletcher and Huang 2006).  
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Fig. 2: Schematic representation of the two major apoptotic pathways: the intrinsic pathway and the exstrinsic 
pathway. 
18 
 
THE CROSSTALK BETWEEN APOPTOSIS AND AUTOPHAGY 
 
Both apoptosis and autophagy are highly regulated processes and increasing evidences suggest a 
possible relation among these pathways. Apoptosis is a mechanism of controlled cell death which 
allows the elimination of damaged or unnecessary cells without damaging contiguous cells. 
Autophagy, on the other end, can be involved in the turnover of long-lived proteins and whole 
organelles, but it also act as a process by which cells adapt their metabolism to starvation induced 
by decreased extracellular nutrients or by decreased intracellular metabolite concentrations that 
result from the loss of growth-factor signaling: through the catabolism of macromolecules, 
autophagy generates metabolic substrates to sustain the metabolic needs of the cell. In this 
conditions autophagy de facto suppresses cell death thus avoiding apoptosis, but in several other 
scenarios it constitutes an alternative pathway to cellular demise, called autophagic cell death (type 
II cell death). To simplify we can say that two different types of interplay between the two 
processes can be observed:  
? Both apoptosis and autophagy act as alternative cell death pathways; 
? Autophagy acts as antagonist to block apoptotic cell death by promoting cell survival; 
The interconnection between apoptosis and autophagy has been studied in different cell types and 
in different conditions. A suitable model to study this relation, which is collocated in the first 
scenario,  is represented by the mouse embryonic fibroblasts (MEFs) of Bax-Bak double knockout 
(Bax-/- Bak-/-). These cells, lacking two multiprotein members of the Bcl2 family, are unable to 
activate the intrinsic apoptotic pathway because these proteins are required for MOMP. It has been 
observed that, when treated with DNA damaging agents such as etoposide (a topoisomerase-2 
inhibitor) Bax-/- Bak-/- MEFs fail to undergo apoptosis, as expected, but instead they manifest a 
massive autophagy followed by massive cell death, thus suggesting that autophagy can act as an 
alternative pathway to apoptosis (Shimizu, Kanaseki et al. 2004). Another example of this 
correlation among autophagy and apoptosis was observed both in mouse L929 and in  human 
Jurkat T cell lymphoma, where the chemical inhibition of caspases induces autophagic cell death 
(Madden, Egger et al. 2007). Otherwise, often autophagy is activated to protect cells from 
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apoptosis in adverse conditions. For example, in an IL3-dependent immortalized cell line , IL3 
withdrawal activates a month long autophagic process causing a severe reduction of cell size and 
the removal of most cytoplasm: inhibition of autophagy in this case kills these cells, thus 
demonstrating that in this case autophagy acts as a protective mechanism (Lum, Bauer et al. 2005).  
This hypothesis is further supported by the observation that both in HeLa and HCT116 cancer cells  
the inhibition of autophagy, either at early or late stages, results in an accelerated apoptotic cell 
death (Boya, Gonzalez-Polo et al. 2005; Gonzalez-Polo, Boya et al. 2005). In vivo, moreover, it has 
been observed that the neuron-specific knockout of Atg5 or Atg7 causes neurodegeneration, 
accumulation of cytoplasmic inclusion bodies and apoptotic cell death (Hara, Nakamura et al. 
2006; Komatsu, Kominami et al. 2006). Autophagy protective effect against apoptosis is not only 
due to its capacity to defend cells from nutrient deprivation: autophagy, indeed, is also essential to 
allow the elimination of cell “waste”, represented by protein aggregates and harmful organelles. 
For example, it has been observed in mutant mice in which Atg5 or Atg7 is depleted an increased 
development of neurodegeneration also in non stressed cells, due to the formation of inclusion 
bodies containing protein aggregates (for example of mutant huntingtin, a protein which results 
mutated in familial forms of Parkinson’s disease). Curiously it has been observed that rapamycin 
treatment, which induces autophagy, can cause a 50% decrease of cell size thus reducing the 
susceptibility of cells to apoptotic stimuli; this observation could be explained, for example by the 
fact that damaged mitochondria are eliminated through mitophagy  to protect cells from their 
potential damaging effects (Fumarola, La Monica et al. 2005).  
The crosstalk between apoptosis and autophagy is clearly demonstrated by the evidences collected 
so far, but it also is suggested by the fact that many common players can be observed among the 
two processes. For example, Atg5 is one of the basic components of the autophagic machinery and 
it is essential for the elongation of the autophagosome membrane during vacuole formation. Atg5 
overexpression, otherwise, not only induces autophagy, but also can activate apoptotic cell death. It 
has been observed indeed that Atg5, upon proper stimuli, can undergo proteolysis, thus generating 
a 24kDa  fragment which translocates to mitochondria where it promotes MOMP (Yousefi, 
Perozzo et al. 2006). Moreover, Atg5 can also directly interact with FADD, thus stimulating the 
extrinsic apoptotic pathway (Pyo, Jang et al. 2005). Another important player of the autophagic 
machinery is beclin-1 which, when associated with its binding partners (VPS34 and UVRAG), 
20 
 
regulates the initial steps of autophagy. Interestingly, beclin-1 contains a BH3 domain, similar to 
that of Bcl2 protein which allows its binding to antiapoptotic Bcl2 homologues. Beclin1, indeed, 
can be inhibited by multidomain proteins of the Bcl2 family, including Bcl2 itself, BclxL and Mcl1 
(Furuya, Yu et al. 2005; Pattingre, Tassa et al. 2005; Maiuri, Criollo et al. 2007; Maiuri, Le 
Toumelin et al. 2007). The binding of beclin-1 to these proteins avoids its association with its 
binding partners, thus inhibiting autophagy. The autophagy-inhibitory effects of Bcl2 or BclxL 
depend on their subcellular localization: only ER-localized but not mitochondrial proteins can bind 
to and inhibit beclin-1. Signals that promote autophagy induce the disruption of the association 
among Bcl2/BclxL and beclin1: for example, phosphorylation of beclin1 by the death-associated 
protein kinase (DAPk) or Bcl2 phosphorylation by JNK trigger the release of beclin-1 and the 
induction of autophagy; alternatively, other BH3-only proteins, such as BNIP3 competitively 
displaces beclin-1.  
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PROTEIN KINASE C 
 
Protein kinase C (PKC) is an ubiquitous family of enzymes that consists of 10 structurally related  
70-80 kDa serine/threonine kinases. PKCs have a multitude of cellular substrates and they are 
involved in a great array of biological processes. The mammalian PKC isotypes have been grouped 
into three  small subfamilies according to their structural properties and their regulation (Mellor and 
Parker 1998): 
? conventional PKC (cPKCs):    α,βI,βII  (produced by an alternatively spliced gene) and 
γ. These isotypes are activated by phosphatidylserine (PS) in a Ca2+-dependent manner and 
by diacylglycerol (DAG), which increases their specificity for PS and shifts the affinity for 
Ca2+ into the physiological range. cPKC can also be activated by phorbol ester (PMA), 
which eliminates the requirement dor DAG and increases the Ca2+ concentration necessary 
for activation. 
? novel PKC (nPKCs):  ε,η , δ, and θ. These proteins are Ca2+-insensitive and they are 
activated by DAG or PMA in presence of PS. 
? Atypical PKC (aPKCs): λ/ι  and ζ. These isoforms are Ca2+-insensitive, nor do they respond 
to DAG or PMA. 
Structure of PKC 
The examination of the protein sequence of different PKC isoforms, shows a clear homology 
between the members of the same subfamily. In all cases highly conserved regions have been 
shown to define protein domains which confer a specific localization or a specific activating input 
to the isotype. The single polypeptide chains of each isoform contain conserved (C) and variable 
(V) regions and are composed of a catalytic and a regulatory domain The catalytic domain is active 
without cofactors after proteolytical removal of regulatory domain . In the regulatory region we can 
find different domains playing different roles. 
? C1 domain is defined by two zinc-finger motifs (C1a and C1b) and each motif has a 
conserved pattern of cysteine and histidine residues, responsible for the coordination of two 
Zn2+ ions. C1 domain represents the binding site for PMA and DAG, which compete for the 
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binding to the site. Structural studies demonstrated that in presence of PMA this domain 
forms an hairpin-like hydrophobic structure that mediates PKC interaction with the 
membrane. C1 site is present in all PKC isoforms, also in aPKC which are DAG and PMA-
insensitive; this can be explained by the fact that aPKC only shows C1a motif which confers 
lower affinity to PMA and DAG than C1b, as demonstrated by mutational studies.  
? C2 domain is found in the cPKC immediately C-terminal to the C1 domain and it is 
composed  by two four-stranded antiparallel β-sheets forming a compact β-sandwich . This 
domain binds two Ca2+ ions thanks to five aspartate residues, thus triggering a 
conformational change which allows the binding o a phospholipid. nPKC and aPKC show 
C2-like domains in which one or more of the aspartate residues necessary for Ca2+ binding  
are missing. Probably the role of C2-like domain is the regulation of protein-protein 
interaction. 
? The pseudosubstrate domain is present in all PKCs subfamilies and it is located at the N-
terminus of the C1 domain. The pseudosubstrate is a sequence which retains the hallmarks 
of a PKC phosphorylation site, but it has an alanine at the predicted serine/threonine  
phosphorylation site. In resting conditions the pseudosubstrate site interacts with the 
catalytic domain and it is responsible for the intramolecular suppression of its catalytic 
activity. 
 
Also in the catalytic region different regions playing different roles can be found: 
? The V3 region is a variable region separating the regulatory domain from the catalytical 
domain. It is sensitive to the proteolytical  activity of Ca2+-dependent proteases like trypsin 
or calpain and the cleavage of this region allows the removal of regulatory domain and the 
activation of  the protein. 
? The C3 domain is an highly conserved region presenting the binding site for ATP.  
? The C4 domain is the proper kinasic domain where the transfer of a phosphate group to the 
substrate takes place. 
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Fig. 3: Schematic representation of different PKC subfamilies structure: classical PKC (C-PKC), novel PKC (N-
PKC) and atypical PKC (A-PKC). 
 
PKC regulation and localization 
PKCs are produced as inactive precursors which are then phosphorylated in three different sites. 
Once fully processed and phosphorylated, PKCs can respond to different second messengers, 
depending on their C1 or C2 domains, and they phosphorylate their downstream targets. 
Activated PKCs are subjected to phosphatase activity and downregulation by ubiquitination and 
proteasomal degradation. PKCs display different sensitivities toward activators. The most 
important activators of PKC are Ca2+, PMA, DAG and PS, which bind to their specific site (see 
PKC structure), by inducing a conformational variation and the subsequent dissociation of the 
regulatory domain. Removal of regulatory domain can also be produced by the protelytical 
cleavage of V3 region. Phorbol esters mimic the action of second-messenger DAG but, while 
production of second messenger DAG in response to physiological stimuli is transient due to the 
rapid metabolic conversion of DAG, phorbol esters are more stable, so their action is much 
more prolonged. DAG and PMA are not the only lipidic mediators involved in PKC activation: 
nPKC and aPKC, for example, can be activated by products of Phosphoinositide 3-kinase (PI3-
K), while aracidonic acid increases DAG effects at low Ca2+ concentrations; ceramide, finally, 
can activate both members of aPKC family. Another interesting aspect of PKC regulation is the 
localization of different isoforms which results from the interaction with specific proteins. 
There are many proteins binding kinases and, while some of them act as a substrate, some 
others are involved in defining their localization to specific cellular compartments. For example, 
while vinculine, MARKS (myristoylated alanine-rich C kinase substrate), α and γ adducine, 
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glycogen syntase and annexin I and II act as PKC substrates, RACKS (receptors for activated 
kinases), upon binding to specific sequences,  drive PKC activation state and define their 
subcellular distribution, thus leading the association with phospholipide to form stable 
membrane complexes. Binding of PKC to membrane induces conformational changes that 
expose the binding site of the kinase domain. The subsequent downstream events include 
activation of the MEK-ERK and PI3K-AKT pathways. PKCs activation therefore is 
accompanied by their translocation, so to better understand the specific action of each isoform it 
is very important to know their localization in resting condition and upon stimulation. Through 
the construction of chimeric proteins given by the fusion of different PKC isoforms with Green 
Fluorescent Protein (GFP) it was possible to define the localization of different PKCs isoforms 
by using digital microscopy techniques, (Rizzuto, Carrington et al. 1998). In resting conditions 
PKCs localization is mainly cytosolic, but for PKCδ and PKCε it was also described a 
localization at the Golgi apparatus, while for PKCδ a nuclear localization was described. Upon 
stimulation, represented for example  by oxidative stress, the α, β, γ and δ isoforms translocate 
to the plasma membrane, while λ and ζ isoforms translocate to the nucleus (Rimessi, Rizzuto et 
al. 2007). The nuclear translocation of some PKC isoforms is made possible by the fact that in 
the regulatory domain of these isoform two sequences named Nuclear Localization Sequence 
(NLS) and Nuclear Export Sequence (NES) can be found and these sequences regulate the 
trafficking of the protein into and out of the nucleus (Perander, Bjorkoy et al. 2001). 
 
Atypical PKC 
Our study focused the attention on the ζ member of the atypical subfamily of PKC. In the last 
years many studies were performed to enlighten the role of this protein in cell life and the 
mechanisms in which it is involved. 
First of all PKCζ (and its homologue λ) is a critical mediator of mitogenic signal, so it is 
directly involved in cell proliferation. The mechanism is not yet completely clear, but it seems 
to be based on the interaction of the enzyme with RAS protein. Moreover PKCζ can activate 
both MAPK and MEK, thus inducing cycline synthesis and, consequently, cellular proliferation 
(Kampfer, Windegger et al. 2001; Cohen, Lingen et al. 2006).  
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Another important aspect is the involvement of PKCζ in the physiological action of insulin. A 
study performed on 3T3-L1 cells demonstrated that  upon insulin stimulation PKCζ is activated 
through the action of lipidic mediators such as PI3K (Bandyopadhyay, Sajan et al. 2002). 
Moreover it has been demonstrated that PKCζ overexpressing cells, upon insulin stimulation, 
show an increased translocation of GLUT-4, demonstrating an involvement of the protein in the 
regulation of glucose homeostasis insulin-regulated (Liu, Yang et al. 2007). PKCζ, finally, is 
involved in the synthesis insulin-stimulated of proteins, through the activation of the kinase 
p70S6K which regulates the proteic transcription (Chou, Hou et al. 1998). 
 
Our work is focused on the involvement of PKCζ in the regulation of apoptosis. Apoptosis is a 
mechanism of programmed cell death in which, following cell damage, mitochondria release 
cytochrome C, which allows the activation of APAF-1 and the consequent activation of caspase 
cascade. In resting conditions, caspase 9 is inactive thanks to the phosphorylation of the serine 
144. PKCζ is one the kinases responsible for the phosphorylation of caspase 9, so it is involved 
in its inactivation. This effect collocates PKCζ among proteins with an antiapoptotic action 
(Brady, Allan et al. 2005).   
  
PKCζ, therefore, is involved in two basic processes of cell life: cell proliferation and apoptosis. 
Interestingly the altered regulation of these processes represents the basis for the tumorigenic 
process, thus suggesting a possible involvement of PKCζ in this event. Many studies have been 
performed to investigate this possible role. For example Filomenko, in 2002, demonstrated that, 
in leukemic cells (U937), the treatment with chemoterapic agents such TNFα and etoposide (a 
topoisomerase II inhibitor) induces a transient increase in PKCζ phosphorylation and 
subsequent activation, thus reducing cell sensitivity to the antitumoral agent. The same effect 
was described on cancer cells from colon (HT29) (Filomenko, Poirson-Bichat et al. 2002). In 
the same year Bezombes performed another study on leukemic cells (HL60 and U937) which 
demonstrated that PKCζ increases the resistance of cells to chemoterapic drugs such as 
Daunorubicine (DNR) and 1-b-D arabinifuranosylcitosine (ara-c), two drugs commonly used in 
antileukaemic therapies, thanks to their ability to induce apoptosis through sphingomyelinase 
activation and ceramide production. PKCζ, indeed, can reduce apoptosis by inactivation of 
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sphingomyelinase and subsequent reduction of ceramide production (Bezombes, de Thonel et 
al. 2002). More recently, the same group showed that the overexpression of PKCζ resulted in 
the abrogation of UV-C induced sphingomyelinase activation and subsequent lack of ceramide 
production and apoptosis inhibition; moreover PKCζ overexpression results in a decrease in 
UV-C induced ROS production (Charruyer, Jean et al. 2007). All these studies underline a 
central role of PKCζ in the development of resistance to chemoterapic drugs, thus suggesting 
the kinase as a possible target to increase the effectiveness of anticancer therapies. 
 
Protein kinase C and redox stress 
Several unique structural aspects of  PKC make it an highly susceptible direct target for 
oxidants as well as chemopreventive oxidants. Both the regulatory and the catalytic domains of 
PKC contain cysteine-rich regions that are targets for redox regulation. Currently the 
accumulating evidences suggest a model in which selective oxidative modifications of the 
regulatory domain leads to constitutive activation , whereas higher concentrations of oxidants 
react with catalytically important cysteine residues and inactivate the enzyme.  For example the 
high concentration of cysteine residues in the zinc fingers of the regulatory domain make it an 
attractive target for redox regulation; moreover the strong binding of redox-inert zinc to 
thiolates enhances their redox sensitivity: the charged zinc-thiolate are, indeed, susceptible to 
oxidation by negatively charged oxidants. Oxidative modifications of zinc thiolates releases 
zinc from these proteins, thus presumably modifying their structure and functions. In the case of 
PKCs oxidants destroy the zinc-finger conformation, thus producing the loss of phorbol ester 
binding activity and of autoinhibitory function and permitting a cofactor-independent catalytic 
activity. The catalytic domain of PKC also contains several cysteines that are required for 
functional kinase activity. Unlike the zinc-thiolates, catalytic domain cysteine are uncoordinated 
and they are free to react with alkylating agents and antioxidants in their oxidized form. Certain 
chemopreventive and growth-inhibiting agents can inactivate PKC by oxidizing the thiols that 
are needed for catalytical activity. One of the most used substances to mimic redox stress is 
represented by hydrogen peroxide (H2O2). Both regulatory and catalytic domain of PKC are 
susceptible to oxidative modification of H2O2. In particular at lower concentrations H2O2 
selectively modifies the regulatory domain; as a consequence, the kinase activity becomes 
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cofactor-independent. On the contrary, sustained peroxide treatment causes PKC 
downregulation.  For example PKCβ can be activated by low H2O2 concentrations (100μM), as 
demonstrated by two independent studies performed by our group . In 2007, indeed we 
demonstrated that in presence of low H2O2 concentrations PKCβ is activated resulting in the 
phosphorylation of p66Shc which can be recognized by the isomerase Pin and can translocate to 
mitochondria where it can act as an oxidoreductase (Pinton, Rimessi et al. 2007). In 2008 we 
published a work demonstrating that redox stress induced by hyperglycemia, but also low 
concentration of H2O2, induce PKCβ activation, and the subsequent activation of the adipogenic 
differentiation program (Aguiari, Leo et al. 2008). 
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p66 
 
In mammalians, three different Shc genes have been found: ShcA, ShcB and ShcC. In my work I 
focused my attention on the ShcA gene, coding for two mRNA species: p66Shc and p46/p52Shc 
(which generates two proteins, p46Shc and p52Shc, because of an alternative translation start). Each 
ShcA protein shows three identical functional domains: 
? An N-terminal phospho-tyrosine-binding domain (PTB), which can bind to phospholipids, 
implying a role of PI3K in the activation of Shc proteins; this domain is slightly truncated in 
the p46Shc isoform; 
? A central proline-rich domain (CH1); 
? A carboxyl terminal Src homology 2 (SH2) domain, which is important for the interaction 
with some receptors, such as EGF-receptor and ErbB-2. 
The p66Shc isoform differs from p46 and p52 for an additional N-terminal proline-rich domain 
(CH2). 
 All three ShcA proteins, but in particular p46 and p52, are involved in the mitogenic signaling and, 
as a consequence, in oncogenesis, by regulating the signaling mediated by the receptor tyrosine 
kinase. The activation of the ShcA proteins is due to their phosphorylation which can be induced 
through different pathways: on one hand insulin induces tyrosine phosphorylation of Shc proteins 
via a PI3K-dependent mechanism involving the PTB domain (Kavanaugh and Williams 1994), on 
the other hand, the phosphorylation of tyrosines in the CH1 domain of Shc is due to  the interaction 
among the SH2 domain of the protein and the EGF-receptor, which acts as a tyrosine-kinase.  
Tyrosine phosphorylation of p46 and p52 enables them to bind to the adaptor protein Grb2, which 
then recruits the guanine nucleotide exchange factor SOS, causing Ras activation and the 
subsequent activation of the MAP kinase cascade. The isoform p66 only plays a marginal role in 
this pathway: it competes, indeed, with p46 and p52 for Grb2 binding, thus acting as a dominant 
negative regulator of p46 and p52-mediated Ras signaling (Bonfini, Migliaccio et al. 1996; 
Migliaccio, Mele et al. 1997; Faisal, Kleiner et al. 2004; Yannoni, Gaestel et al. 2004). The main 
role of p66 is due to its involvement in the regulation of the redox stress response. p66, indeed, is 
mainly localized into the cytoplasm and it has been demonstrated that, in redox stress conditions, it 
can be phosphorylated by PKCβ at the Ser36, which is critical for its function. When 
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phosphorylated, p66 is recognized by the prolyl-isomerase Pin1 and it can translocate to 
mitochondria, where it acts as an oxidoreductase and increases mitochondrial ROS production  
(Pinton, Rimessi et al. 2007). When located in the mitochondrial intermembrane space, p66 
oxidizes cytochrome c, making it unavailable to reduce oxygen to water (Nemoto, Combs et al. 
2006). A fraction of the mitochondrial electron flow is, therefore, deviated to the production of 
H2O2, which induces the opening of the PTP, the subsequent MOMP and the release of cytochrome 
c which induces apoptosis . So we can say that p66 sensitizes the cells to the deleterious effects of 
ROS, thus increasing their sensitivity to apoptosis. Interestingly, it has been observed that the 
knocking out of the p66 gene in mice determines a lifespan extension of 30%, without alterations in 
food intake or weight gain (Migliaccio, Giorgio et al. 1999): wild-type mice, indeed, have an 
average lifespan of 761 days, whereas heterozygous or homozygous mice have, respectively, an 
average lifespan of 815 or 973 days. Functional studies suggest that this effect on the lifespan 
should be due to an higher capacity of p66Shc-/- to perform detoxification from ROS and to repair 
damaged DNA. p66Shc-/- mice, moreover, survive 40% longer than wt mice to an intraperitoneal 
injection of paraquot, an oxidant-generating compound, thus suggesting that p66Shc is involved in 
the resistance to an acute redox stress. At the cellular level, p66Shc plays a crucial role in the 
regulation of oxidative stress response and apoptosis. Mouse embryonic fibroblasts (MEFs) derived 
from p66Shc-/-, indeed,  show a basal level of ROS production comparable to that  of wt cells, but 
p66Shc-/- cells show a lower level of ROS production upon H2O2 treatment and an increased 
resistance to apoptosis (Migliaccio, Giorgio et al. 1999; Pinton, Rimessi et al. 2007).  
ROS play a crucial role in many processes, thus suggesting that p66 should act as a central actor in 
many phenomena. For example, many pathological conditions are accompanied by an increase of 
ROS production, so the study of a possible p66Shc involvement in these phenomena should suggest 
a possible molecular target to attend. First of all, diabetes affects more than 150 million people 
worldwide and it is estimated it would increase in the next years. Among the full spectrum of 
biochemical effects of high glucose, generation of ROS is one of the main pathophysiological 
mechanisms linking hyperglycemia to atherosclerosis, nephropathy and cardiomyopathy, which are 
the main complications accompanying diabetes. For this reason, a possible involvement of p66Shc 
in these phenomena was hypothesized. In 2003 Pelicci  and his group investigated the role of p66 in 
atherosclerosis, thus underlying that p66 loss reduces vascular cell apoptosis and early 
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atherogenesis in mice following high-fat diet (Napoli, Martin-Padura et al. 2003). The same group 
observed that p66 is involved both in age-related and in diabetes-induced endothelial dysfunction, 
thus suggesting that p66-produced ROS play a central role in age-associated diseases and also that 
p66Shc acts as a downstream target of hyperglycemia-activated PKCβ (Francia, delli Gatti et al. 
2004; Camici, Schiavoni et al. 2007). Diabetes-associated hyperglycemia also causes an enhanced 
glomerular cell death by apoptosis, generating the so called diabetic nephropathy. In this regard a 
study performed in 2006 showed that p66 loss protects from this complication by blocking 
hyperglycemia-induced ROS production and oxidant-dependent renal tissue injury (Menini, 
Amadio et al. 2006). Finally, it has been demonstrated that p66 ablation prevents oxidative damage 
in cardiac progenitor cells and myocytes, thus preserving cardiac function in diabetes and reducing 
the complications consisting of the reduction of left ventricular compliance and consequent 
impairment of systolic function and heart failure which are associated with this pathology (Cesselli, 
Jakoniuk et al. 2001). A recent study performed by Pelicci and co-workers also underlines an 
involvement of p66 in the development of obesity: in adipocytes, when activated by insulin indeed 
p66 generates H2O2 thus reducing mitochondrial oxygen consumption and favoring triglyceride 
accumulation. However, mice lacking p66, show an increased basal metabolism, a reduced fat 
development, an increased insulin sensitivity of peripheral tissues and a reduction of body weight 
(Berniakovich, Trinei et al. 2008). Finally, a study performed on the skeletal muscle of mice, 
demonstrated that p66 deletion results in a faster regeneration of skeletal muscle following ischemia 
or cardiotoxin treatment due to reduced redox stress; moreover, satellite cells of p66Shc-/- mice 
proliferate faster and display an higher rate of spontaneous differentiation that wt cells (Zaccagnini, 
Martelli et al. 2007).  
All of this observation suggest an appearently unsolvable contradiction: why does the natural 
selection conserved a gene which apparently only plays damaging functions? The answer to this 
question is not yet known and for this reason many efforts are concentrated to clarify all possible 
p66Shc action, in order to understand why a so damaging gene has been conserved by the nature. 
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AIMS 
 
ROS are highly reactive molecules or ions formed by the incomplete one-electron reduction of 
oxygen. In healthy conditions ROS are produced by the cell mainly at the mitochondrial level, as a 
consequence of the activity of the respiratory chain, and then they are eliminated by a series of 
scavenging molecules and enzymes in order to minimize their damaging effects. Many pathological 
conditions are characterized by an imbalance among ROS production and ROS scavenging, which 
results in an accumulation of ROS. Tumor development is an example of condition characterized by 
an accumulation of ROS. Malignant cells, indeed, show higher levels of endogenous oxidative 
stress, mainly due to a decrease in the activity of the scavenging enzymes and to an increase of 
ROS production as a consequence of an impaired activity of the respiratory chain due to an 
accumulation of mtDNA mutation. Also diabetes is characterized by an increase in cellular ROS  
production determined by hyperglycemia, which is a key feature of this disease. Protein kinase C ζ 
(PKCζ) is a serine-threonine kinase belonging to the atypical subfamily of PKC. PKC is an 
ubiquitous family of kinases consisting of 10 members performing a multitude of functions in cell 
life and death. All the members of the PKC family are sensitive to the redox state and they can be 
activated by an increase of radical oxygen species (ROS) . In this work we focused our attention on 
one particular isoform of the atypical subfamily: PKCζ. In particular we have investigated the 
behavior of this protein in condition of redox stress and its effects on cell life: we observed that 
redox stress induces a translocation of PKCζ from the cytosol, where it is located in resting 
condition, to the nucleus and that this translocation exerts a protective effect from apoptotic stimuli. 
Many previous studies suggested that PKCζ is directly involved in the development of 
chemoresistance of cancer cells (Bezombes, de Thonel et al. 2002; Filomenko, Poirson-Bichat et al. 
2002).  The purpose of our work was to confirm an hypothesis which puts in the same picture all 
the previous observations: in cancer cells an increase of ROS production and a reduction of the 
scavenging systems activity produces an oxidative stress which activates PKCζ thus inducing its 
translocation to the nucleus; this translocation is a key event to determine an increased resistance to 
chemotherapic drugs, as observed by other groups. 
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 Another protein involved in redox stress regulation and sensitivity is p66, an adaptor protein 
known to be involved in aging and in many pathological conditions like diabetes and its 
complications. Many studies in the last years were focused in dissolving the apparent contradiction 
around p66: why the evolutionary selective pressure conserved this appearently damaging gene? 
Mice knockout for p66, indeed, show a lifespan extension of 30% compared to the wt mice, p66Shc-/- 
mice, moreover,  are protected by obesity and by the complications associated with diabetes. Our 
group investigated the effect of p66 on cell viability showing that, following a redox stress which 
activates the kinase PKCβ, p66 is phosphorylated on the Ser36 and, in this form, it is recognized by 
the prolyl isomerase Pin1, which modifies its conformation thus allowing p66 translocation to 
mitochondria, where it acts as an oxidoreductase and it increases mitochondrial ROS production, 
thus rendering cells more sensitive to the apoptotic effects of an exogenous redox stress. P66Shc-/-, 
indeed, are more resistant to the apoptotic effects of H2O2, thus confirming a central role of the 
protein in the sensitivity to apoptosis (Pinton, Rimessi et al. 2007). The following year our group 
published an other work showing that hyperglycemia induces an increase in ROS production which 
activates PKCβ thus inducing the adipogenic differentiation of muscle derived stem cells, which 
were expected to differentiate into myotubes, thus suggesting a central role for PKCβ in this 
“transdifferentiation” program (Aguiari, Leo et al. 2008). In both cases ROS-induced PKCβ 
activation plays a key role and, intuitively, p66 is also involved in the adipogenic 
transdifferentiation of  muscle derived stem cells. The purpose of our work was double: on one 
hand we wanted to investigate a possible role of p66 in the adipogenic transdifferentiation of 
muscle-derived stem cells as downstream target of PKCβ and to reproduce our previous observation 
in an in vivo model; on the other hand we wanted to investigate a possible role of p66 in regulating 
autophagy and in particular we hypothesized a possible role of p66 as a switch among the apoptotic 
and the autophagic pathways.  
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PKCζ RESULTS 
Protein kinase C is a family of ubiquitous protein kinases consisting of 10 members classified in 
three different subfamilies: conventional PKC (cPKCs) α,βI,βII (produced by an alternatively 
spliced gene) and γ; novel PKC (nPKCs) ε,η , δ, and  θ; atypical PKC (aPKCs) λ/ι  and  ζ. In this 
work we focused our attention on one particular isoform of the atypical subfamily: PKCζ. In 
particular we have investigated the behavior of this protein in condition of redox stress and its 
effects on cell life: we observed that redox stress induces a translocation of PKCζ from the cytosol, 
where it is located in resting condition, to the nucleus and that this translocation exerts a protective 
effect from apoptotic stimuli. Interestingly we also observed that this protective effect is directly 
involved in the chemoresistance of cancer cells to chemoterapic drugs like doxorubicin.  
As demonstrated by our group in a previous report (Rimessi, Rizzuto et al. 2007), oxidative agents 
induce modifications of the intracellular distribution of specific PKC isoforms in HeLa cells and 
remarkable differences were observed among the different subgroups. The approach we used to 
monitor the localization of PKC proteins by digital microscopy was based on the construction of a 
chimeric protein PKC-GFP,  where the cDNA coding for each isoform was fused with the HA1 
epitope derived from haemagglutinin and with the green fluorescent protein (GFP). As shown in 
Fig.1A, in HeLa cells the chimeric protein PKCζ−GFP uniformly localizes throughout the 
cytoplasm  in resting conditions, as expected for resting PKC, while upon oxidative stress 
conditions it partly translocates to the nucleus. Redox stress conditions were mimicked in vitro by a 
1mM hydrogen peroxide treatment, a concentration inducing, after 2 hours, about 45% of cell death 
(data not shown). The trafficking cytosol-nucleus is due to the fact that, in the regulatory domain of 
PKCζ  two different regions can be found: a nuclear localization sequence (NLS), responsible for 
PKCζ nuclear translocation, and a nuclear export sequence (NES), responsible for its diffusion from 
the nucleus to the cytoplasm; these regions are responsible for the continuous shuttling of atypical 
PKC between the cytoplasm and the nucleus (Perander, Bjorkoy et al. 2001). To exclude that  
PKCζ  activation and translocation was due to its overexpression we also monitored endogenous  
behavior by using specific  antibodies: as shown in Fig.1B, in resting conditions the protein is 
diffused into the cytoplasm, while in oxidative conditions it is redistributed mainly into the nucleus 
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and partly into the cytoplasm. Hydrogen peroxide is not the only stimulus inducing PKCζ  nuclear 
translocation: also UVc treatment, indeed induce nuclear PKCζ  translocation (data not shown).  
We then correlated the nuclear translocation of PKCζ mediated by oxidizing agent with its effect on 
cell viability. Two approaches were performed: the microscopic assessment of cell survival 
(apoptotic counts), and the caspase-3 activity assay (see materials and methods).  HeLa cells were 
transiently transfected with PKCζ-GFP alone, and 36 h after transfection they were treated with 
different concentrations of H2O2 in order to underline a possible dose-dependence of the effect . 
After 2 h of incubation with the oxidative stimulus, we observed an apparent increase in the 
percentage of PKCζ-expressing cells after treatment (Fig. 1C-I). The increase in the percentage of 
positive cells correlates with a pro-survival role of the expressed chimera compared to mock cells. 
The pro-survival effect we observed resulted proportional  with the increase of H2O2 concentration; 
this observation is apparently in contrast with the apoptotic effect of H2O2 which, in this case, plays 
a dual role: on one hand it induces PKCζ translocation to the nucleus, thus protecting PKCζ 
overexpressing cells from its own damaging effect, on the other hand it acts as an apoptotic 
stimulus thus reducing the total number of living cells. Similar results were obtained by monitoring 
the Caspase-3 activity, expressed as normalized value of fluorescence intensity (Fig. 1C-II). At 
H2O2 1mM,  the levels of caspase-3 activity in PKCζ-overexpressing HeLa cells were lower than 
H2O2-treated control cells. Moreover we observed that the inhibition of PKCζ, mediated by specific 
PKCζ-Pseudosubstrate-Myristoylated Inhibitor, restores the apoptotic-sensitivity in H2O2-treated 
cells, thus suggesting that the protective effect is specifically due to PKCζ . Overall, these data 
indicate that the nuclear PKCζ-redistribution, promoted by oxidative agent,  enhances pro-survival 
response. Finally, to verify if the antiapoptotic effect we observed is specific for PKCζ, we  
compared the effects on apoptosis of  the activation and localization of  different PKC isoforms 
upon  an oxidizing treatment: HeLa cells were transiently transfected with PKCζ-GFP, PKCα-GFP, 
PKCε-GFP and mitochondrial GFP (Mock) respectively, and treated with 1mM H2O2 for 2 hours. 
Through apoptotic count assay we observed that the apoptotic sensitivity results unchanged in 
mock, PKCα and PKCε-overexpressing cells, while the pro-survival capacity of PKCζ in these 
conditions, was confirmed (Fig1D). 
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Fig. 1: Redox stress induces PKCζ nuclear translocation protecting PKCζ overexpressing HeLa cells by its own 
apoptotic effects.  A)PKCζGFP overexpressing HeLa cells in resting condition (left) and after a 30 minutes  treatment 
with H2O2 1mM (right); histograms represent the ratio between the nuclear fluorescence and the cytosolic fluorescence, 
expressed as a percentage, before and after the treatment. B) Immunofluorescence of endogenous PKCζ in HeLa cells 
in resting conditions and following a 30 minute treatment with H2O2 1mM. C) i) Apoptotic counts in PKCζ -GFP 
overexpressing HeLa cells: the histograms represents the difference of percentage of fluorescent cells on the total 
number of living cells following a 30min treatment with different H2O2 concentrations (50uM, 100uM, 1mM, 2mM), 
compared to resting conditions; ii) Caspase 3 activity assay: the caspase 3 activity is expressed as a normalized value 
of  fluorescence intensity. Gray line: untreated HeLa cells; orange line: HeLa cells treated with PKCζ  
pseudosubstrate-myristoilated commercial inhibitor; black line; PKCζ -GFP overexpressing HeLa cells; cyan line: 
mock HeLa cells treated with 1mM H2O2; green line: PKCζ -GFP overexpressing HeLa cells treated with 1mM H2O2; 
purple line: PKCζ-GFP overexpressing HeLa cells treated both with the pseudosubstrate- myristoilated inhibitor and 
with H2O2 1mM. D) Apoptotic counts in HeLa cells overexpressing chimeric protein of different PKC isoforms (PKCα, 
PKCε, PKCζ) fused with GFP, compared to mock cells: the histograms represent the difference of percentage of 
fluorescent cells on the total number of living cells following a 30 minutes treatment with H2O2 1mM compared to 
resting conditions. 
 
 
PKCζ-translocation prevents cell death induced by apoptotic stimuli 
Two important points emerged, so far: I) the oxidative stress promotes the nuclear translocation of 
PKCζ; II) the nuclear localization of the kinase protects cells from  oxidative stress.  We  then tried 
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to investigate the role of the nuclear translocation of PKCζ and first of all we asked if the pro-
survival effect of nuclear PKCζ is specific for oxidative damage and if nuclear PKCζ-redistribution 
also protects  cells from other apoptotic agents. As shown in figure 2A, we analysed the effects on 
the kinase distribution and cellular viability in PKCζ-GFP overexpressing HeLa cells treated with 
different apoptotic agents: a calcium-dependent agent (ceramide 30μM), a strong serine-threonine 
phosphatase inhibitor (okadaic acid 0.5μM) and a monoclonal anti-FAS antibody (4μg/ml) were 
used to induce apoptosis. After a two hours treatment, we monitored the PKCζ distribution by 
digital imaging microscopy and we investigated the cellular viability by apoptotic count assay, as 
described above. The same experiments were performed in PKCζ-GFP expressing cells pre-treated 
with H2O2 to promote the preventive nuclear translocation of the chimera.  To induce PKCζ nuclear 
translocation by minimizing the apoptotic effect of hydrogen peroxide, we  treated HeLa cells with  
100 μM H2O2 for 30 minutes: this concentration only induces  4.9 ± 1.1% of cell death in HeLa 
cells and in ∼ 40% of cells, the nuclear PKCζ-redistribution, was evident (Fig.2A). The apoptotic 
effects were compared: as shown on the panels 2A-I, 2A-II and 2A-III (on the left), no change in 
the distribution of kinase was induced by the apoptotic agents in PKCζ-GFP expressing cells. The 
observation that none of the apoptotic agents we analyzed induces per se PKCζ translocation to the 
nucleus correlates with their effect on cell viability of PKCζ expressing cells, which are not 
protected by their apoptotic effects (ceramide-treated cells: Δ% -5.3 ± 1.11 ; okadaic acid-treated 
cells: Δ% 2.0 ± 1.21; anti-Fas-treated cells: Δ% Δ% -1.4 ± 1.73). PKCζ expressing cells are 
protected by the apoptotic agents only if they are previously treated with 100uM H2O2 to induce a 
preventive nuclear translocation of the kinase: in this case PKCζ expressing HeLa cells are 
protected by the apoptotic effect of ceramide (Δ% +12.1 ± 0.95) and of okadaic acid (Δ% +14.5 ± 
1.23), but not by the apoptotic effect of anti-FAS (Δ% 1.6 ± 1.57). This observation appears to be 
contradictory with our hypothesis, but it can be explained by the fact that anti-FAS alters H2O2-
induced PKCζ nuclear localization, as shown in Fig.2A right panel. Moreover Anti-fas  is different 
from the other stimuli we observed, because it activates the extrinsic apoptotic pathway instead of 
the mitochondrial one.  All  these observations further suggest that PKCζ, when localized into the 
nucleus, protects cells from apoptosis induced by different stimuli. To determine whether the pro-
survival effect was caused predominantly by nuclear localization of PKCζ, independently from 
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redox stress conditions, HeLa cells were treated with leptomycin B (LMB, 4ug/ml 2h) which 
inhibits the NES-dependent nuclear export of many proteins (and among them also PKCζ) by 
interfering with the binding of NES domain to CRM1/exportin 1 (Kudo, Matsumori et al. 1999). 
This inhibition leads to considerable nuclear accumulation of endogenous PKCζ (Fig. 2C-II). We 
have evaluated the effects of this phenomenon on cellular viability, in ceramide-treated cells. As 
shown in Fig.2CI, the pre-treated LMB cells were preserved from ceramide-induced apoptosis (Δ% 
cells viability in pre-treated LMB cells: -13.4 ± 7.03 vs. -47.2 ± 8.33 in LMB untreated cells, after 
apoptotic treatment). No change in apoptotic sensitivity was observed in LMB-treated HeLa cells 
(Δ% cells viability in pre-treated LMB cells: -11.0 ± 3.38).  
38 
 
 
Fig. 2: Nuclear PKCζ protects HeLa cells by different apoptotic stimuli. A) H2O2 (100uM 30 min.) pretreatment 
induces PKCζ nuclear translocation in PKCζ-GFP overexpressing cells thus protecting them from the apoptotic effects 
of (i) ceramide (30uM 2 h) and (ii) okadaic acid (0.5uM 2h), (iii) but not from the apoptotic effects of anti-Fas 
(4ug/ml). The upper panels show PKCζ-GFP overexpressing HeLa cells following the apoptotic stimulus (left) and 
following the apoptotic stimulus but previously accompanied by H2O2 100uM pretreatment (right). The lower panel 
shows apoptotic counts of PKCζ-GFP overexpressing HeLa cells; the histograms represents the difference of 
percentage of fluorescent cells on the total number of living cells following the different treatments compared to resting 
conditions. B) (i) LMB (4ug/ml 2h) pretreatment induces PKCζ nuclear accumulation in PKCζ-GFP overexpressing 
cells, thus protecting them from the apoptotic effects of ceramide (30uM 2h); the histograms represent the difference of 
percentage of fluorescent cells on the total amount of living cells after the treatment compared to resting conditions. 
(iii)  Immunofluorescence of endogenous PKCζ: effect of LMB 4ug/ml 2h. 
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Nuclear chimeras of PKCζ prevent apoptotic death by ceramide 
 
 The data collected so far clearly suggest a pro-survival pathway mediated by the nuclear localized 
PKCζ. To better investigate this pathway we obtained nuclear-targeted PKCζ chimeras. This 
approach allowed us to  selectively investigate the role of nuclear PKCζ independently from redox 
stress conditions. To completely sort PKCζ to the nucleus, a nuclear targeting sequence from 
Glucochorticoid Receptor was  fused with PKCζ cDNA at its C terminus (nuPKCζ, Fig. 3A-I). The 
digital images  showed both  nuclear and partly cytosolic distribution of the chimera. To completely 
focus on the nuclear portion of the kinase, a constitutively-active nuclear-targeted PKCζ was 
obtained from nuPKCζ by eliminating its regulatory domain, containing both the autoinhibitory 
domain and the nuclear import and export sequences (nuPKCζ-act, Fig. 3A-II). Specific nuclear 
staining was detected in nuPKCζ-act expressing HeLa cells. To better validate the specific 
localization of our chimeras, a quantification of the nuclear distribution of the chimeric protein was 
performed in HeLa cells transfected with PKCζ-GFP and both nuclear chimeras respectively. As 
emerges from figure 3B, the level of nuclear localization of nuPKCζ-act (expressed as a ratio 
among nuclear and cytosolic fluorescent intensity) was more than ten-fold higher than PKCζ-GFP 
and only five-fold higher than  nuPKCζ (nuPKCζ-act 4.71 ± 0.80 or nuPKCζ 2.76 ± 0.41 vs. 0.41 ± 
0.03 for PKCζ-GFP). To confirm the specific pro-survival role of nuclear PKCζ, we then carried 
out apoptotic count measurements in PKCζ-GFP, nuPKCζ, and nuPKCζ-act expressing cells 
exposed to the Ca2+-dependent apoptotic stimulus ceramide. According to our hypothesis, the 
preventive nuclear distribution and activation of nuPKCζ-act chimera mediated by deprivation of 
regulatory domain prevented apoptotic cell death induced by ceramide (Fig. 3C), suggesting that 
the forced recruitment of constitutively active PKCζ into the nucleus, represents a pivotal step for 
the pro-survival cellular response (cell viability in nuPKCζ-act cells: Δ% 12.6 ± 0.40 vs -5.3 ± 1.11 
in PKCζ-GFP expressing Hela cells). Interestingly, the nuclear localization of the kinase, if not 
accompanied by its constitutive activation, only partially affected the apoptotic sensitivity to 
ceramide, as demonstrated by nuPKCζ expressing cells  (nuPKCζ expressing cells Δ% -6.3 ± 1.08 
vs -5.3 ± 1.11 in PKCζ-GFP expressing Hela cells). All these results contribute to underlying the 
pleiotropic role of PKCζ in apoptosis. PKCζ has been reported to be anti-apoptotic (Berra, Diaz-
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Meco et al. 1993), and so far its effect was described to be mostly exerted at the transcriptional 
level, for example through the control of  the expression levels of Bcl-2 family members and other 
apoptotic regulators  (Filomenko, Poirson-Bichat et al. 2002). According to these observations we 
showed that active-PKCζ translocates into the nucleus thus preventing cell death induced by 
different apoptotic agents. Moreover, many observations demonstrated an involvement of PKCζ 
overexpression in the development of chemoresistance by neoplastic cells (Bezombes, de Thonel et 
al. 2002) and it was described that PKCζ inhibition promotes apoptosis in leukemic cells exposed to 
etoposide and tumor necrosis factor α, as well as it sensitizes to etoposide tumor cells grown in 
nude mice. These results suggest thus that PKCζ reduces the sensitivity of cancer cells to 
chemotherapic agents and they indicate that this kinase may be a useful target for tumor cell 
chemosensitization. However, it is quite difficult to design an effective therapeutic approach 
selectively based on PKCζ, because of the high structural affinity among the different PKC 
isoforms, and because of  the complexity of the functions and of the interactions of PKCζ and its 
non specific action. A key  purpose of our efforts was to develop specific PKCζ-inhibitor which 
selectively impairs the nuclear PKCζ-activity, indeed starting from the observations showing  
PKCζ as a target for tumor cells chemosensitization,  a selective nuclear inhibitor will contribute to 
potentiate the activity of the chemotherapic agents. To obtain a selective nuclear PKCζ inhibitor we 
applied the same strategy previously used to obtain nuclear PKCζ-chimeras. The peptide sequence 
corresponding to the  pseudosubstrate domain on PKCζ (thirteen amino acids in length at positions 
113-125), and thereby inhibiting the kinase activity in resting conditions (Laudanna, Mochly-Rosen 
et al. 1998; Dang, Fontayne et al. 2001) was fused at the C terminus of the chimeric protein given 
by the fusion of GFP and nuclear targeting sequence (nu-inhPKCζ). Fig.3D shows a representative 
scheme of the inhibitor, and its specific nuclear distribution in HeLa cells. The protective effect of 
the inhibitor was assessed in apoptotic count experiments, where nu-inhPKCζ expressing HeLa 
cells were pretreated with LMB and exposed to apoptotic agent (Fig. 3E). As describe above, the 
LMB treatment induces nuclear accumulation of endogenous PKCζ by inhibiting the nuclear export 
system, thus protecting cells by ceramide-induced apoptosis (Fig.2C). In nu-inhPKCζ expressing 
cells, the nuclear distribution of PKCζ-inhibitor (which does not affect cell viability per se –data 
not shown-) impaired the pro-survival effect mediated by the treatment with LMB. The inhibitor, 
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indeed, markedly  reverted the sensitivity to ceramide-induced apoptosis in LMB pre-treated cells, 
whereas, no change was observed in nu-inhPKCζ expressing cells only treated with LMB (Δ% cells 
viability in pre-treated LMB cells: -4.6 ± 2.31 vs -60.0 ± 8.60 after ceramide treatment). A marked 
increase in the incidence of apoptosis ceramide-induced was also assed in nu-inhPKCζ expressing 
cells without LMB pretreatment (Δ% cells viability: -48.6 ± 8.71). 
In conclusion, different experimental approaches allowed us to evidence an important effect of 
nuclear PKCζ in the regulation of the sensitivity to apoptotic stimuli. Moreover, we showed the 
possibility to affect the fate of cells, either promoting cell survival (through the expression of 
nuclear PKCζ-chimeras) or cell death (through the expression of nuclear PKCζ-inhibitor). 
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Fig. 3: Effects of constitutively nuclear PKCζ (nuPKCζ), constitutively active and constitutively nuclear PKCζ 
(nuPKCζ-act) and selectively nuclear PKCζ inhibitor (nu-inhPKCζ) on cell viability. A) Cellular localization and 
structure of the chimeric proteins nuPKCζ (i) and nuPKCζ-act (ii). B) Nuclear localization of the different PKCζ 
mutants: the histograms represent the ratio between the nuclear fluorescence and the cytosolic fluorescence, expressed 
as a percentage, of the three chimeric proteins in resting conditions. C) Apoptotic counts of HeLa cells expressing the 
different PKCζ mutants following a ceramide treatment (30uM 2h); the histograms represents the difference of 
percentage of fluorescent cells on the total amount of living cells after the treatment compared to resting conditions. D) 
Cellular localization and structure of the selectively nuclear PKCζ inhibitor (nu-inhPKCζ). E) Effects of nu-inhPKCζ 
overexpression on cell viability following LMB (4ug/ml 2h) pretreatment and/or C2-ceramide (30uM 2h) treatment. The 
histograms represents the difference of percentage of fluorescent cells on the total amount of living cells after the 
treatment compared to resting conditions. 
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The nuclear PKCζ‐inhibitor reverts the apoptotic effect of Doxorubicin in 
chemotherapeutic-resistant cells 
 
In order to validate the efficacy of the selectively nuclear PKCζ-inhibitor, we tested it on HeLa 
cells resistant to the commonly used chemotherapeutic agent doxorubicin. We selected 
doxorubicin-resistant HeLa clones (DrHeLa cells) by culturing HeLa cells in presence of a low 
doxorubicin concentration (2μM). We than evaluated the chemosensitivity of our DrHeLa clones by 
treating two of them (clone1-2) with the antineoplastic drug (2μM) and assessed the rate of cell 
death in comparison with mock HeLa cells. After 36 h of treatment with  the chemotherapic agent, 
we observed a marked resistance of DrHeLa clones to the compound used, whereas mock cells 
displayed an high rate of cell death (Fig. 4A). 
Recent evidences further suggests the involvement of oxidative stress in anticancer drug resistance 
(Trachootham, Lu et al. 2008). Cancer cells are able to survive to intrinsic oxidative stress through 
an adaptation-process involving the activation of redox-sensitive survival machineries. Indeed, 
according to these observation, we observed a significant increase of ROS production in DrHeLa 
clones compared  to mock cells (Fig. 4B). The increased amount of  ROS levels  favours the nuclear 
translocation of PKCζ in doxorubicin-resistant HeLa cells, as shown in Fig. 4C (clones 1-2), as 
demonstrated by the fact that the nuclear level of the kinase was more than three-fold higher in 
anticancer drug-resistant cells than mock cells (mock cells: 0.43 ± 0.04 vs 1.31 ± 0.16 1.11 ± 0.10 
in clone 1 or 2, respectively). To ensure that the nuclear PKCζ-activity selectively confers the 
anticancer drug resistance, we tested the effect of nuclear PKCζ-inhibitor on cell survival of 
DrHeLa cells. As expected, the expression of nu-inhPKCζ did not affect per se the viability of 
resistant cells (Fig. 4D), but following a doxorubicin treatment (3h or 24h), nu-inhPKCζ expression 
in DrHeLa cells, abolished the resistance of cells to the anticancer drug,  making them drug-
sensitive (nu-inhPKCζ expressing DrHeLa cells, clone1: 46.8 ± 5.23 vs 28.3 ± 2.75 or 26.1 ± 1.33 
after 3h or 24h of doxorubicin-exposition, respectively; clone2: 41.9 ± 5.66 vs 25.7 ± 1.45 or 16.6 ± 
1.74). 
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Fig. 4: Role of PKCζ nuclear translocation in chemoresistance. A) Doxorubicin resistance of two different clones 
selected by culturing HeLa cells in presence of Doxorubicin 2μM. The graph represents a time course of cell viability 
of 3 different clones of HeLa cells: a mock clone (black line) and two selected doxorubicin-resistant clones of HeLa 
cells (grey and dark gray). B)  Time course of ROS production, expressed  as normalized values of fluorescence 
intensity of the three clones (mock and doxorubicin-resistant HeLa cells). The histograms represent the increase in ROS 
production expressed as a percentage. C) Immunofluorescence of endogenous PKCζ in mock HeLa cells and in two 
different clones of doxorubicin-resistant HeLa cells. The histograms on the right represents a ratio between the nuclear 
fluorescence and the cytosolic fluorescence in the three different clones. D) Apoptotic counts of two different clones of 
doxorubicin-resistant HeLa cells transiently expressing nu-inhPKCζ. The histograms represents the difference of 
percentage of fluorescence following different doxorubicin treatment (2μM 3h or 24h) compared to resting conditions. 
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PKCζ DISCUSSION 
 
 
Protein kinase C ζ (PKCζ) is a serine-threonine kinase belonging to the atypical subfamily of PKC. 
PKC is an ubiquitous family of kinases consisting of 10 members performing a multitude of 
functions in cell life and death. All the members of the PKC family are sensitive to the redox state 
and they can be activated by an increase of radical oxygen species (ROS) (see Introduction). ROS 
are highly reactive molecules or ions formed by the incomplete one-electron reduction of oxygen. 
In healthy conditions ROS are produced by the cell mainly at the mitochondrial level, as a 
consequence of the activity of the respiratory chain, and then they are eliminated by a series of 
scavenging molecules and enzymes in order to minimize their damaging effects. Many pathological 
conditions are characterized by an imbalance among ROS production and ROS scavenging, which 
results in an accumulation of ROS. Tumor development is an example of condition characterized by 
an accumulation of ROS. Malignant cells, indeed, show higher levels of endogenous oxidative 
stress, mainly due to an increase of ROS production as a consequence of an impaired activity of the 
respiratory chain due to an accumulation of mtDNA mutations (Czarnecka, Kukwa et al. 2010). As 
just said, the different members of PKC show a sensitivity to the redox state, indeed they can be 
activated by an increase of ROS levels. PKCs activation is expressed as a translocation from the 
cytoplasm, where they are located in resting conditions, to a particular cell compartment, depending 
on the single isoform. In particular, a study performed by our group, investigated the behavior of 
different PKC isoforms belonging from the classical and novel subfamilies upon activation, 
showing that following activation they preferentially translocate to the plasma membrane. In this 
work, we focused our attention on PKCζ, a member of the atypical subfamily which shows a 
different behavior compared to the other members: indeed,  when activated by redox stress 
(mimicked by H2O2 1mM treatment) PKCζ, both the endogenous and the overexpressed, 
translocates to the nucleus (Fig.1A 1B). This behavior is due to the presence in its regulatory 
domain, of two regions, called the nuclear localization sequence (NLS) and the nuclear export 
sequence (NES), which regulate its trafficking into and out of the nucleus. In this case H2O2 acted 
as a stimulus inducing PKCζ nuclear translocation, but it also is classically  known as an apoptotic 
stimulus activating the intrinsic apoptotic pathway. For this reason we investigated the effect on cell 
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viability of PKCζ nuclear translocation through the apoptotic counts and we interestingly observed 
that PKCζ overexpressing cells are protected by the damaging effects of H2O2. We further 
confirmed this observation by performing a caspase-3 activity assay (see Material and methods) 
which showed that the protective effect of PKCζ against the damaging effects of H2O2 are due to a 
reduced activation of caspase-3 and of the apoptotic pathway. This effect, moreover, is specific for 
PKCζ activation, as demonstrated by the fact that PKCζ inhibition with a specific commercial 
inhibitor (see Material and Methods) can revert the effect, thus inducing caspase 3 activation. The 
central role of nuclear PKCζ in the protective effect we observed was further confirmed by the 
specific inhibition of nuclear PKCζ by a nuclear inhibitor obtained by the autoinhibitory domain of 
the kinase targeted to the nucleus (Fig.3D). Moreover, the specificity of PKCζ effect was confirmed 
by the fact that, in the same conditions, other PKC isoforms do not show any significant effect on 
cell viability compared to PKCζ, as expected considered that the other PKC isoform do not show a 
nuclear translocation. Paradoxically we also observed that PKCζ protective effect increases with the 
increase of H2O2 concentration (Fig.1C).This effect is due to the fact that in this case H2O2 plays a 
dual effect: on one hand indeed, according to our previous observations, it induces PKCζ specific 
nuclear translocation, thus protecting PKCζ overexpressing cells from apoptotic cell death, while 
on the other hand it acts as an apoptotic stimulus acting on the intrinsic pathway, thus inducing PTP 
opening, MOMP and consequently cell death. The global effect is an increase of the percentage of 
PKCζ overexpressing cells on the total amount of living cells. The protective effect of PKCζ, 
moreover, is not specific for redox stress damaging effects: the kinase, indeed, can also protect from 
other apoptotic stimuli such as the Ca2+-dependent agent C2-Ceramide (30μM) and the strong 
serine-threonine phosphatase inhibitor Okadaic acid (0.5μM). According to our previous 
observations PKCζ does not protect cells per se, but it exerts its effect only when located into the 
nucleus, as demonstrated by pretreating cells with a low H2O2 concentration (100μM), which 
induces the translocation without significantly affecting cell viability (Fig.2A). An apparently 
discordant observation concerns the effect of PKCζ following the apoptotic stimulus Anti-Fas 
(4μg/ml): in this case, indeed, PKCζ does not show any  protective effect, nor per se, nor following 
H2O2 pretreatment.  However Anti-Fas, is different from the other stimuli used in our experiments 
because, while H2O2, C2-ceramide and Okadaic acid activate the intrinsic apoptotic pathway, Anti-
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Fas acts activating the extrinsic one, thus suggesting a specific effect of nuclear PKCζ on the 
mitochondrial pathway. Moreover, as shown in Fig.2AIII, Anti-Fas seems to act on the 
permeability of nuclear membrane, thus altering PKCζ nuclear localization. The key role of PKCζ 
nuclear localization in the antiapoptotic effect we observed was further confirmed by using other 
different approaches: on one hand, indeed, we induced PKCζ nuclear accumulation by pretreating 
PKCζ overexpressing cells with Leptomycin B (LMB), which alters the nuclear export (Fig.2CII), 
while on the other hand we obtained chimeric proteins, such as nuPKCζ, a constitutively nuclear 
PKCζ, and nuPKCζ-act, a constitutively active and constitutively nuclear PKCζ (Fig.3A, Fig.3B). 
As expected, in both cases we confirmed our previous observation: when located into the nucleus, 
PKCζ protects cells from apoptotic stimuli like C2-ceramide (Fig.2C, Fig.3C). This hypothesis was 
further confirmed by the specific inhibition of nuclear PKCζ (Fig.3D), which does not alter cell 
viability per se (data not shown), but it can revert the protective effect of nuclear PKCζ after LMB 
pretreatment (Fig.3E). Many studies performed by different groups (Bezombes, de Thonel et al. 
2002; Filomenko, Poirson-Bichat et al. 2002) suggested a role for PKCζ in the development of 
resistance of cancer cells to chemoterapic drugs such as the topoisomerase 2 inhibitor etoposide and 
Doxorubicin. For this reason, we tried to investigate if the nuclear localization of the kinase is 
involved in this phenomenon. To this purpose we tested the effect of specific nuclear PKCζ 
inhibition on the chemoresistance  of two different Doxorubicin-resistant HeLa clones. These cells 
are characterized by an increase in ROS levels compared to control HeLa cells (Fig.4B) and, as 
expected, in these conditions endogenous PKCζ is partly located into the nucleus. (Fig.4C). Our 
previous data suggest that nuclear PKCζ should be involved in Doxorubicin-resistance, as 
demonstrated by the effect of nuclear specific PKCζ inhibition, which significantly reverts 
Doxorubicin resistance (Fig.4D).  All these data suggest a central role of nuclear PKCζ in 
regulating cell viability, and in particular the sensitivity to apoptotic cell death, thus altering the 
resistance of cancer cells to the effect of chemoterapic drugs. These observations suggest a possible 
therapeutical approach to increase the efficacy of antineoplastic drugs by modulating nuclear PKCζ. 
Many aspects, however, should be more deeply investigated: the antiapoptotic role of PKCζ indeed 
was already described, but the previous works concerning this topic only suggest an effect at the 
cytosolic level (for example through sphingomyelinase inactivation -(Bezombes, de Thonel et al. 
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2002)- or caspase 9 activation -(Brady, Allan et al. 2005)-), while this work describes an effect at 
the nuclear level. Moreover we did not described the molecular pathway activated by nuclear 
PKCζ. To further analyze this aspect an in silico analysis could be helpful to select some genes 
correlated with the protein. Moreover, a microarray analysis performed on a clone of nuPKCζ-act 
could suggest some possible target involved in the antiapoptotic effect of nuclear PKCζ, thus 
enlightening the molecular pathway involved in the effect we described. 
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p66 RESULTS 
 
 
p66 is an adaptor protein known to be involved in aging and in many pathological conditions like 
diabetes and its complications. Many studies in the last years were focused in dissolving the 
apparent contradiction around p66: why the evolutionary selective pressure conserved this 
appearently damaging gene? Mice knocked-out for p66, indeed, show a lifespan extension of 30% 
compared to the wt mice, p66Shc-/- mice, moreover,  are protected from obesity and from the 
complications associated with diabetes. Our group investigated the effect of p66 on cell viability 
showing that, following a redox stress which activates the kinase PKCβ, p66 is phosphorylated on 
the Ser36 and, in this form, it is recognized by the prolyl-isomerase Pin1, which modifies its 
conformation thus allowing p66 translocation to mitochondria, where it acts as an oxidoreductase 
and it increases mitochondrial ROS production, thus rendering cells more sensitive to the apoptotic 
effects of an exogenous redox stress. p66Shc-/-, indeed, are more resistant to the apoptotic effects of 
H2O2, thus confirming a central role of the protein in the sensitivity to apoptosis  (Pinton, Rimessi 
et al. 2007). The following year our group published another work showing that hyperglycemia 
induces an increase in ROS production which activates PKCβ thus inducing the adipogenic 
differentiation of muscle derived stem cells, which were expected to differentiate into myotubes, 
thus suggesting a central role for PKCβ in this “transdifferentiation” program (Aguiari, Leo et al. 
2008). In both cases ROS-induced PKCβ activation plays a key role and, intuitively, p66 is also 
involved in the adipogenic transdifferentiation of  muscle derived stem cells. The purpose of our 
work was dual: on one hand we wanted to investigate a possible role for p66 in the adipogenic 
transdifferentiation of muscle-derived stem cells as downstream target of PKCβ and to reproduce 
our previous observation in an in vivo model; on the other hand we wanted to investigate a possible 
role of p66 in regulating autophagy and in particular we hypothesized a possible role of p66 as a 
switch among the apoptotic and the autophagic pathways.  
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p66 and the adipogenic differentiation of muscle-derived stem cells 
 
In the work published by our group in 2008 (Aguiari, Leo et al. 2008) we showed that the exposure 
of a culture of muscle-derived stem cells to high glucose concentrations (25mM), determines  in an 
unidentified precursor cell type (expected to differentiate into skeletal muscle) the activation of the 
adipogenic program, as demonstrated by an increase in the expression level of PPARγ and Srebp-
1c, two classical transcription factors involved in the activation of the adipogenic program.  The 
key event of this process is the activation of PKCβ induced by the hyperglycemia-induced ROS 
production. The first purpose of our work was to confirm in an in vivo model our observations: we 
asked, indeed, if the activation of PKCβ also plays a role in inducing the adipogenic differentiation 
of skeletal muscle precursor in vivo. The model we used is the tibialis anterior of mice belonging to 
the C57BL6 strain. The first approach we chose was the electroporation, because it is the most 
efficient method to introduce exogenous genes into skeletal muscle cells (Smith and Nordstrom 
2000). Our purpose was to induce, at the same time,  PKCβ overexpression in order to mimic the 
experiments performed in vitro, and a degenerative-regenerative response of skeletal muscle thus 
activating stem cells, by modulating the voltage.  We applied a voltage of 330V/cm, chosen as a 
compromise between  the necessity to obtain a good percentage of transfection and, at the same 
time, a degenerative response, revealed by the presence of fibers showing central nuclei. According 
to our hypothesis, this voltage should determine an inflammatory response (Babiuk, Baca-Estrada et 
al. 2004), which induces ROS production, thus reproducing in vivo the same conditions we created 
in vitro (Fig.5).  
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Fig. 5: Induction of muscle damage by electroporation. A) Hematoxilin/Eosin staining of transversal sections of T.A 
muscles. T.A. were electroporated with different voltages (220V/cm, 330 V/cm, 440V/cm). B) GFP staining and 
Hematoxilin/Eosin staining of transversal sections of T.A. muscles. T.A were cotransfected with PKCβ-GFP and H2-
RED Histon to mark nuclei. 
 
These experiments, however showed no adipocytes accumulation in PKCβ overexpressing muscles,  
because through the electroporation we only transfected the mature fibers and not the precursor 
cells which are responsible for the adipogenic differentiation (Dona, Sandri et al. 2003). For this 
reason we used a new approach based on the activity of endogenous PKCβ: we induced a massive 
damage to the skeletal muscle of mice by using different approaches (Fig.6A): freeze injury (i), 
glycerol injection (50%v/v, ii) H2O2 injection (250mM, iii)  and . The first kind of muscle damage 
we tested was freeze injury: we cut the skin and exposed the tibialis anterior, then we applied to the 
muscle a plate previously frozen in liquid nitrogen. For H2O2, or glycerol injection, after cutting the 
skin, we injected 50μl of the solution into the muscle. 7 days after the damage, the animals were 
sacrificed and the tibialis anterior was extracted, frozen in 2-metilbutane and transversal section 
were obtained, both to extract proteins or to perform different stainings such as haematoxylin/eosin 
staining, to analyze the morphological features of the muscle, or Oil RedO (ORO) staining, which 
marks adipocytes, by accumulating into the lipid droplets. Interestingly, 7 days after freeze-injury-
induced damage we observed an ORO positive staining, due to an accumulation of adipocytes 
among the muscle fibers.  Because this approach allowed us to reproduce in vivo the model we 
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described in vitro, we applied it to answer our question: does PKCβ activation plays a role in 
inducing the adipogenic differentiation of skeletal muscle precursor in vivo? To answer this 
question, being impossible to selectively transfect the precursor cells with PKCβ gene, we decided 
to compare wt mice with p66Shc-/- mice, being p66Shc the putative downstream target of PKCβ. 
We applied freeze injury on the tibialis anterior muscle of wt and p66Shc-/- mice and after 5 days 
we sacrificed the animals and extracted the muscles, because it has been described that lipid 
accumulation after freeze injury increases from 3 to 5 days after the damage (Wagatsuma 2007). 
Interestingly, while ORO staining didn’t show any difference between wt and p66 KO mice (data 
not shown), a biochemical analysis performed by western blot of Srebp-1c, a transcriptional factor 
involved in the initial phases of the adipogenic program which, for example, mediates insulin 
effects in hepatic gene expression, showed that while in resting conditions no differences are 
detectable in different tissues of wt and p66KO mice (Fig.6B), after freeze injury p66KO mice 
show a reduced level of cleaved Srebp-1c, resulting in a reduced activation of the adipogenic 
program, as expected according to our hypothesis (Fig.6C). The fact that ORO staining does not 
evidence lipid accumulation in this conditions is probably due to the fact that the adipogenic 
program is in an initial phase and lipid accumulation is not yet detectable. Moreover, recent 
evidences suggest that Srebp-1c cleavage and subsequent activation can be also induced by ER-
stress, for example in liver (Kaplowitz and Ji 2006), so we analyzed the levels of ER-stress of wt 
and p66KO skeletal muscle, by measuring the expression levels of Xbp1 and GRP78, a well known 
marker of ER stress and, according to our previous observation, we observed that p66KO also show 
a reduced level of ER-stress after freeze injury Fig.6C). The same observation were collected after a 
damage induced by redox stress produced by an H2O2 injection: a reduced ER-stress in the p66KO 
corresponds to a reduced cleavage of Srebp-1c and a consequent reduction of the adipogenic 
program activation, suggesting a role of p66 in the activation of the adipogenic program induced by 
redox stress. 
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Fig. 6: Freeze-injury and glycerol injection induce intramuscular adipocytes accumulation. A) Oil RedO staining of 
transversal sections of T.A. muscles. Degenerative-regenerative response was induced by freeze-injury (i),  glycerol 
injection (50% v/v) (ii) or H2O2 injection (250mM) (iii) . B) Levels of endogenous Srebp-1c and XbpI in resting 
condition of different tissues of wt or p66KO mice, detected by Western blot analysis of tissue lysates. C) Levels of 
endogenous Sprebp-1c and XbpI of T.A. of Wt mice compared to p66KO mice after freeze-injury. The level of the 
protein was detected by Western blot analysis of muscle lysates. 
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p66 and autophagy 
 
 
As demonstrated by our group, p66 plays a key role in regulating the sensitivity of cells to the 
apoptotic effect of redox stress. Moreover increasing evidence suggest that it exist a tight crosstalk 
between the apoptotic and the autophagic pathway, as demonstrated by the fact that the two events 
share many molecular regulators. The first purpose of our work was to investigate a possible 
involvement of p66 in the autophagic pathway. We obtained primary cultures of myotubes (see 
Material and methods) from wt and p66KO mice and removed the serum for 19 hours. The 
activation of the autophagic pathway was analyzed by Western blot of LC3, the most known 
marker of autophagy, which is lipidated when autophagy is active.  In serum starvation condition 
no difference was detectable between wt and p66KO cells. Basing on the fact that p66 is directly 
involved in ROS sensitivity, we hypothesized that the protein could be involved in ROS-induced 
autophagy. To confirm this hypothesis, we treated myotubes with H2O2 100uM. Interestingly, in 
this condition we observed that, while in wt cells autophagy is blocked, in KO cells redox stress 
induces the autophagic pathway (Fig.7A). This effect, otherwise, is not dose dependent. When cells 
are treated with 1mM H2O2, indeed, no difference is detectable between wt and KO cells: in both 
cases the autophagic pathway is activated (data not shown). We confirmed the effect of p66 on 
autophagy following a redox stress in an in vivo model: we injected H2O2 2mM in the tibialis 
anterior of wt and KO mice and after 5 days we sacrificed the animals and extracted the muscle. 
According to our previous data, we observed that also in vivo a redox stress blocks autophagy in wt 
animals, while it induces autophagy in KO animals (Fig.7B). These data suggest that p66 not only 
is involved in the sensitivity of ROS-induced apoptosis, as previously demonstrated, but it also is 
involved in ROS-induced autophagy. The different behavior of wt and KO cells and animals, 
indeed suggests a possible role of p66 as a switch between the two processes: wt cells, following a 
redox stress activate the apoptotic pathway involving p66 and its mitochondrial oxidoreductase 
activity, while KO cells, being unable to activate the apoptotic pathway involving p66, activate the 
autophagic pathway, as an alternative death program (Fig.7C-Hp1). Another possible explanation 
of the different level of lipidated LC3 upon redox stress between wt and p66KO cells is that p66 
could be involved in autophagosome degradation: in this case the amount of lipidated LC3 in KO 
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cells should mark an autophagosome degradation instead of an induction of the autophagic 
pathway (Fig.7C-Hp2). 
 
56 
 
 
Fig. 7: Role of p66 in the regulation of autophagy. A) Level of endogenous LC3 in myotubes from Wt and KO mice 
in different conditions: serum starvation 19h, H2O2 treatment 100uM 2h and serum starvation 19h in presence of H2O2 
100uM. B) Level of endogenous LC3 in lysates from Wt and KO T.A. in control muscles compared to H2O2 250mM-
injected muscles. Muscle lysates were obtained 7 days after the injury. C) Models representing two possible hypothesis 
explaining p66 involvement in autophagy regulation. 
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p66 DISCUSSION 
 
 
p66Shc is an adaptor protein known to be involved in the regulation of lifespan, in different 
pathological conditions,  and in many processes like adipogenesis (Wagatsuma 2007) and muscle 
regeneration (Zaccagnini, Martelli et al. 2007), mainly thanks to its activity as a mitochondrial 
oxidoreductase (Giorgio, Migliaccio et al. 2005). Different works by us and other groups underlined 
a central role of ROS in the control of cell viability and of adipogenesis. In particular, we suggested 
a central role of the pathway ROS-PKCβ  in these phenomena. In mef cells, indeed, redox stress 
induced by H2O2 treatment activates PKCβ which phosphorylates the protein p66. In this form p66 
is recognized by the prolyl-isomerase Pin1, which induces a conformational change in p66 thus 
allowing its translocation to mitochondria, where it acts as an oxidoreductase and sensitizes cells to 
the apoptotic effects of redox stress. P66 KO mef cells otherwise are protected by apoptosis in the 
same conditions (Pinton, Rimessi et al. 2007).  The pathway ROS-PKCβ is also involved in the 
mechanisms allowing the adipogenic differentiation of pluripotent muscle-resident precursors. 
Myogenic precursors, indeed, when cultured in presence of high glucose concentration (25mM) 
generate adipocytes because hyperglycemia induces an increase of ROS production thus activating 
PKCβ and this event is the basis for the activation of the adipogenic program (Aguiari, Leo et al. 
2008). Many aspects, otherwise, need to be further investigated. First of all the cell type responsible 
for the adipogenic differentiation has not yet been identified: many undifferentiated cell types, 
indeed, can be involved in this event, such as: 
? satellite cells, which are undifferentiated cells located between sarcolemma and basal 
lamina, committed to myogenic lineage; they are quiescent in adult skeletal muscle but  
upon injury and mechanical load of muscle fibers, they activate, proliferate and eventually 
generate a pool of predeterminated myoblasts which terminally differentiate into myotubes 
by fusion;  
? stem cells, which have a strong capacity for self-renewal (superior to that of satellite cells) 
and have the ability to undergo multipotent differentiation into muscle, blood, vessels, 
peripheral nerve. 
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Recent evidences identified a new mesenchimal progenitor PDGFα-positive, distinct from satellite 
cells,  which, when activated by a muscle damage (induced by glycerol injection), can differentiate 
into adipocytes (Uezumi, Fukada et al. 2010). Moreover, the pathway involving PKCβ and its 
downstream target has not yet been identified, but an overview of our previous data suggests p66 as 
a suitable PKCβ downstream target also in the activation of the adipogenic program.  
Being adipogenic degeneration a common feature of many pathological diseases such as Duchenne 
muscular dystrophy, but also type II diabetes, obesity and age-related sarcopenia, the investigation 
of the mechanisms regulating this process should represent the basis for a therapeutical approach. 
For this reason, our purpose was to confirm the pathway described in vitro in an in vivo model, 
represented by the skeletal muscle (tibialis anterior) of mice, in particular we compared wt mice 
with p66 KO mice. The first approach we used was to induce PKCβ overexpression in myotubes 
and, at the same time to induce a degenerative-regenerative response by electroporating the muscle 
with an opportune voltage (330V/cm). This approach, otherwise, failed because it did not induce 
PKCβ overexpression in the myogenic precursors involved in the differentiation, but only in 
mature myotubes which are obviously not involved in adipogenic differentiation. For this reason 
we decided to work on the endogenous PKCβ and we induced muscle degenerative-regenerative 
response (which is accompanied by an activation of myogenic precursors) by inducing freeze 
injury or injecting H2O2 (250mM) or glycerol (50%v/v). Interestingly, we observed that, 5 days 
after the muscle damage, nor wt nor p66KO show adipocytes accumulation according to Oil RedO 
staining, but the biochemical analysis showed a reduced Srebp-1c cleavage in p66KO extracts 
compared to wt. Srebp1c is a transcription factor involved in the control of cholesterol homeostasis 
and it is known to be activated by cleavage during the early phases of adipogenic program. The 
apparently discordant results obtained with Oil RedO staining, which does not show any significant 
difference in adipocytes accumulation between wt and KO mice, should be due to the fact that the 
adipogenic process is in an initial phase, making adipocytes undetectable. Another possible 
explanation, which need to be further investigated, resides in the fact that recent observations 
suggest Srebp-1c as a marker of ER-stress: in liver, indeed, the unfolded protein response produced 
by ethanol, induces Srebp-1c activation and subsequent cleavage. According to these observations 
we investigated the ER stress levels of wt and p66KO muscles after damage by analyzing the 
classical markers of ER stress Xbp-1 and Grp78  and we observed that p66KO mice show a lower 
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level of ER stress. To establish if in our experimental conditions muscle damage only induces ER 
stress or if it also determines adipocytes accumulation, we should analyze other  markers of 
adipogenic differentiation, such as the transcription factor PPARγ and we also should analyze the 
effect of muscle damage after a longer period to allow a massive adipocytes accumulation in the 
case that the adipogenic program is activated. Moreover, to confirm the involvement of PKCβ in 
our in vivo model, we should design a protocol to silence PKCβ in the myogenic precursors and in 
this condition PKCβ knockdown muscles should show the same behavior of p66 KO mice. Finally, 
once enlightened the molecular mechanisms allowing the adipogenic differentiation of cells 
committed to the myogenic lineage, our purpose should be to confirm the therapeutical interest of 
our observations by modulating this pathway in a pathological model represented, for example, by 
diabetic ob/ob mice or obese “high fat diet” mice.   
The second aspect we investigated was a possible involvement of p66 in the regulation of 
autophagic process. In particular, the crosstalk between apoptosis and autophagy represents an 
interesting topic whose molecular basis have not yet been completely elucidated. Our previous data 
suggest a clear role of p66 in sensitizing cells to the apoptotic effects of redox stress, for this reason 
we decided to investigate its role in the autophagic process. We interestingly observed that, while 
in starvation-induced autophagy no significant difference was detectable between wt and p66 KO 
myotubes, if the starvation is accompanied by redox stress (H2O2 100μM), wt mice do not activate 
autophagy, while KO activate a massive autophagy, both in vitro (cultured myotubes) and in vivo 
(tibialis anterior). This observation can be explained by the fact that in redox stress conditions, 
while wt cells (being sensitized to apoptosis by p66 activation) activate the apoptotic pathway, p66 
KO cells activate the autophagic program. These observations suggest, on one hand, that in redox 
stress conditions autophagy is activated as an alternative to apoptosis and, on the other hand, that 
p66 can act as a molecular switch between the two pathways. To confirm this hypothesis we should 
observe in KO cells a decrease of caspase activity, specular to the increase of LC3 lipidation and 
the restore of p66 should revert this effect. Another possible explanation for the effects we have 
seen is that p66 could be involved in the “off mechanisms” of autophagy, in particular in 
autophagosomes degradation, independently from its effects on apoptosis. To verify this second 
hypothesis we will monitor p62 degradation. p62, indeed, is a protein known to interact with LC3 
and to be degraded by autophagy (Ichimura, Kumanomidou et al. 2008) and, if p66 is necessary to 
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switch off autophagy (as LC3 II accumulation in p66 KO could suggest), p62 should not decrease 
with the progress of the autophagic process.  
The data we collected so far are simply preliminary data which need to be considerably 
investigated, but overall they suggest that p66 is involved in a multitude of phenomena. The 
molecular mechanisms of these  pleiotropic effects need to be deeply investigated in order to 
selectively modulate each effect, thus making p66 a suitable target to modulate different cellular 
mechanisms. 
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MATERIAL AND METHODS 
 
Isolation and Culturing of Myotubes and adipocytes 
Primary cultures of skeletal muscle were prepared from newborn mice (2-3 days). In brief, posterior 
limb muscles were removed and dissociated by two successive treatments with 0.125% trypsin in 
phosphate-buffered saline. The first harvest, which contains mostly fibroblasts and endothelial cells, 
was discarded. The remaining cell suspension was filtered through a double gauze. Cells were 
collected by centrifugation for 10 min at 1200 rpm (Heraeus Minifuge GL), resuspended in HAM’S 
F12, supplemented with 10% fetal bovine serum and then plated in 3-cm Petri dishes at a density of 
1.2 million cells/dish. After 15 minutes non adherent cells were seeded into 3 cm dishes coated with 
10% collagen. After 24 hours the culturing medium was changed with DMEM supplemented with 
2% horse serum to increase myogenic differentiation. Adipocytes were obtained by culturing 
adherent cells obtained after preplating in presence of 25mM glucose in DMEM medium.  
 
Imaging techniques 
All imaging experiments were carried out on Zeiss Axiovert 200 inverted microscopes, equipped 
with cooled CCD digital cameras. Z-series of images were acquired at 0.5 μm distance, 
deconvolved using a custom-made algorithm and 3D reconstructed as described previously 
(Carrington et al., 1995; Rizzuto et al., 1998b). 
 
Caspase-3 assay 
After inducing apoptosis cells were harvested , washed  in phosphate-buffered saline (PBS) and 
than a lysate was obtained by subjecting the cells to a freeze-thaw cycle. During cell lysis, a 
solution of 2X reaction buffer was prepared according to datasheet. The lysated cells were then 
centrifuged to pellet the cellular debris. 50 μL of the supernatant from each sample were then 
transferred to individual microplate wells. 50 μL of the 1X cell lysis buffer was used as a no-
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enzyme control to determine the background fluorescence of the substrate. As an additional control, 
1 μL of the 1 mM Ac-DEVD-CHO inhibitor stock solution was added to selected samples. The 
samples were incubated at room temperature for 10 minutes. The remaining samples (without 
inhibitor) were stored on ice during this time. Then a 2X substrate working solution  was prepared 
according to datasheet and  50ul were added to each sample which than has been incubated for 30 
minutes at room temperature. The fluorescence of each sample (excitation/emission ~496/520 nm) 
was then measured by using appropriate  excitation and emission filters. Because the assay is 
continuous, measurements were performed at multiple time points. 
 
PKCζ-based constructs 
Human PKCζ cDNA (1779 bp), fused with the GFP cDNA, was cloned into the expression vector 
pcDNA3. To obtain the nuclear localization of the kinase, the coding sequence of nuclear 
localization regions of Glucochorticoid receptors (GR- 354bp) was fused with the chimeric protein 
PKCζGFP. The Constitutively active PKCζ mutant was obtained by substituting the entire PKCζ 
cDNA with the catalytic domain (1014 bp) while the nuclear PKCζ inhibitor was obtained by 
substituting the entire PKCζ cDNA with the autoinhibitory domain. 
 
Intracellular ROS measurements 
Intracellular ROS generation was measured with 5-(and-6)-chloromethyl-2_,7_-
dichlorodihydrofluorescein diacetate, acetyl ester (CM-H2DCFDA) (Invitrogen), which is cell-
permeant. After ester hydrolysis, the probe is trapped as a nonfluorescent probe, 5-(and-6)-
chloromethyl-2_,7_-dichlorodihydrofluorescein. After its oxidation by ROS, 5-(and-6)-
chloromethyl-2_,7_-dichlorofluorescein (CM-DCF) green emission was recorded at 520 nM. Cells 
were loaded with 10_MCM-H2DCFDA at 37°C in modified KRB at 5.5 or 25 mM glucose. After 
30 min, laser scanning confocal microscopy images were obtained. Acquisitions were made every 1 
s for 500 s. 
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Animals and In Vivo Transfection Experiments 
 
Experiments were performed on adult C57BL6 mice.  In vivo transfection experiments were 
performed as described previously by injecting DNA and then elettroporating the muscle (Sandri et 
al., 2004). In some experiments, TA were injected with glycerol (50% v/v), cardiotoxin (10uM) or 
H2O2 (250mM) or freeze injury was performed. To induce autophagy mice were starved for 18 
hours.  
 
Muscle samples and Immuohistochemical staining 
Muscles were dissected carefully, freed from any visible fat and blood and rapidly frozen in liquid 
nitrogen-cooled isopentane.  Serial sections (6 μm) were thaw mounted on uncoated precleaned 
(96% ethanol) glass slides. Before processing, or storage at –70°C, the samples were air dried for 
15 min. 
  
ORO staining: Oil red O was obtained from Fluka Chemie (C.I. number 26125; Buchs, 
Switzerland) and dissolved to a stock solution by adding 500 mg oil red O to 100 ml 60% triethyl-
phosphate [(C2H50)3PO; Fluka Chemie]. Prior to staining, a 36% triethyl phosphate working 
solution, containing 12 ml oil red O stock solution and 8 ml deionised water, was prepared. This 
solution was filtered through Whatman paper number 42 (Whatman, Maidstone, UK) to remove 
crystallised oil red Serial sections were fixed (1h) using 3.7% formaldehyde solution in deionised 
water. Excess formaldehyde was removed by three rinses in deionised water for 30 s. Subsequently, 
the sections were immersed in the working solution of oil red O for 30 min. Hereafter, sections 
were washed with three exchanges of deionised water for 3 times 30 s. If desired, sections were 
counterstained using Mayer’s haematoxylin for 60 s to visualise nuclei. Then, sections were rinsed 
with running tap water for 10 min and covered with a coverslip using Fluoromount mounting 
medium (Sigma). 
Hematoxylin\Eosin staining was performed using a kit by Bio-Optica. 
 
 
64 
 
 
 
 
 
 
65 
 
 
BIBLIOGRAPHY 
 
 
Aguiari, P., S. Leo, et al. (2008). "High glucose induces adipogenic differentiation of muscle-
derived stem cells." Proc Natl Acad Sci U S A 105(4): 1226-1231. 
Babiuk, S., M. E. Baca-Estrada, et al. (2004). "Increased gene expression and inflammatory cell 
infiltration caused by electroporation are both important for improving the efficacy of DNA 
vaccines." J Biotechnol 110(1): 1-10. 
Bandyopadhyay, G., M. P. Sajan, et al. (2002). "PKC-zeta mediates insulin effects on glucose 
transport in cultured preadipocyte-derived human adipocytes." J Clin Endocrinol Metab 
87(2): 716-723. 
Berniakovich, I., M. Trinei, et al. (2008). "p66Shc-generated oxidative signal promotes fat 
accumulation." J Biol Chem 283(49): 34283-34293. 
Berra, E., M. T. Diaz-Meco, et al. (1993). "Protein kinase C zeta isoform is critical for mitogenic 
signal transduction." Cell 74(3): 555-563. 
Bezombes, C., A. de Thonel, et al. (2002). "Overexpression of protein kinase Czeta confers 
protection against antileukemic drugs by inhibiting the redox-dependent sphingomyelinase 
activation." Mol Pharmacol 62(6): 1446-1455. 
Bonfini, L., E. Migliaccio, et al. (1996). "Not all Shc's roads lead to Ras." Trends Biochem Sci 
21(7): 257-261. 
66 
 
Boya, P., R. A. Gonzalez-Polo, et al. (2005). "Inhibition of macroautophagy triggers apoptosis." 
Mol Cell Biol 25(3): 1025-1040. 
Brady, S. C., L. A. Allan, et al. (2005). "Regulation of caspase 9 through phosphorylation by 
protein kinase C zeta in response to hyperosmotic stress." Mol Cell Biol 25(23): 10543-
10555. 
Camici, G. G., M. Schiavoni, et al. (2007). "Genetic deletion of p66(Shc) adaptor protein prevents 
hyperglycemia-induced endothelial dysfunction and oxidative stress." Proc Natl Acad Sci U 
S A 104(12): 5217-5222. 
Cesselli, D., I. Jakoniuk, et al. (2001). "Oxidative stress-mediated cardiac cell death is a major 
determinant of ventricular dysfunction and failure in dog dilated cardiomyopathy." Circ Res 
89(3): 279-286. 
Chami, M., A. Prandini, et al. (2004). "Bcl-2 and Bax exert opposing effects on Ca2+ signaling, 
which do not depend on their putative pore-forming region." J Biol Chem 279(52): 54581-
54589. 
Charruyer, A., C. Jean, et al. (2007). "PKCzeta protects against UV-C-induced apoptosis by 
inhibiting acid sphingomyelinase-dependent ceramide production." Biochem J 405(1): 77-
83. 
Cheng, E. H., T. V. Sheiko, et al. (2003). "VDAC2 inhibits BAK activation and mitochondrial 
apoptosis." Science 301(5632): 513-517. 
Chou, M. M., W. Hou, et al. (1998). "Regulation of protein kinase C zeta by PI 3-kinase and PDK-
1." Curr Biol 8(19): 1069-1077. 
67 
 
Cohen, E. E., M. W. Lingen, et al. (2006). "Protein kinase C zeta mediates epidermal growth factor-
induced growth of head and neck tumor cells by regulating mitogen-activated protein 
kinase." Cancer Res 66(12): 6296-6303. 
Crespo, J. L., S. Diaz-Troya, et al. (2005). "Inhibition of target of rapamycin signaling by 
rapamycin in the unicellular green alga Chlamydomonas reinhardtii." Plant Physiol 139(4): 
1736-1749. 
Crespo, J. L. and M. N. Hall (2002). "Elucidating TOR signaling and rapamycin action: lessons 
from Saccharomyces cerevisiae." Microbiol Mol Biol Rev 66(4): 579-591, table of contents. 
Czarnecka, A. M., W. Kukwa, et al. (2010). "Mitochondrial DNA mutations in cancer--from bench 
to bedside." Front Biosci 15: 437-460. 
Dang, P. M., A. Fontayne, et al. (2001). "Protein kinase C zeta phosphorylates a subset of selective 
sites of the NADPH oxidase component p47phox and participates in formyl peptide-
mediated neutrophil respiratory burst." J Immunol 166(2): 1206-1213. 
Delivani, P. and S. J. Martin (2006). "Mitochondrial membrane remodeling in apoptosis: an inside 
story." Cell Death Differ 13(12): 2007-2010. 
Djavaheri-Mergny, M., M. Amelotti, et al. (2006). "NF-kappaB activation represses tumor necrosis 
factor-alpha-induced autophagy." J Biol Chem 281(41): 30373-30382. 
Dona, M., M. Sandri, et al. (2003). "Functional in vivo gene transfer into the myofibers of adult 
skeletal muscle." Biochem Biophys Res Commun 312(4): 1132-1138. 
Faisal, A., S. Kleiner, et al. (2004). "Non-redundant role of Shc in Erk activation by cytoskeletal 
reorganization." J Biol Chem 279(5): 3202-3211. 
68 
 
Filomenko, R., F. Poirson-Bichat, et al. (2002). "Atypical protein kinase C zeta as a target for 
chemosensitization of tumor cells." Cancer Res 62(6): 1815-1821. 
Fletcher, J. I. and D. C. Huang (2006). "BH3-only proteins: orchestrating cell death." Cell Death 
Differ 13(8): 1268-1271. 
Francia, P., C. delli Gatti, et al. (2004). "Deletion of p66shc gene protects against age-related 
endothelial dysfunction." Circulation 110(18): 2889-2895. 
Frezza, C., S. Cipolat, et al. (2006). "OPA1 controls apoptotic cristae remodeling independently 
from mitochondrial fusion." Cell 126(1): 177-189. 
Fujita, N., M. Hayashi-Nishino, et al. (2008). "An Atg4B mutant hampers the lipidation of LC3 
paralogues and causes defects in autophagosome closure." Mol Biol Cell 19(11): 4651-
4659. 
Fumarola, C., S. La Monica, et al. (2005). "Cell size reduction induced by inhibition of the 
mTOR/S6K-signaling pathway protects Jurkat cells from apoptosis." Cell Death Differ 
12(10): 1344-1357. 
Furuya, N., J. Yu, et al. (2005). "The evolutionarily conserved domain of Beclin 1 is required for 
Vps34 binding, autophagy and tumor suppressor function." Autophagy 1(1): 46-52. 
Giorgio, M., E. Migliaccio, et al. (2005). "Electron transfer between cytochrome c and p66Shc 
generates reactive oxygen species that trigger mitochondrial apoptosis." Cell 122(2): 221-
233. 
Gonzalez-Polo, R. A., P. Boya, et al. (2005). "The apoptosis/autophagy paradox: autophagic 
vacuolization before apoptotic death." J Cell Sci 118(Pt 14): 3091-3102. 
69 
 
Hanada, T., Y. Satomi, et al. (2009). "The amino-terminal region of Atg3 is essential for association 
with phosphatidylethanolamine in Atg8 lipidation." FEBS Lett 583(7): 1078-1083. 
Hara, K., Y. Maruki, et al. (2002). "Raptor, a binding partner of target of rapamycin (TOR), 
mediates TOR action." Cell 110(2): 177-189. 
Hara, T., K. Nakamura, et al. (2006). "Suppression of basal autophagy in neural cells causes 
neurodegenerative disease in mice." Nature 441(7095): 885-889. 
Hosokawa, N., T. Hara, et al. (2009). "Nutrient-dependent mTORC1 association with the ULK1-
Atg13-FIP200 complex required for autophagy." Mol Biol Cell 20(7): 1981-1991. 
Ichimura, Y., T. Kumanomidou, et al. (2008). "Structural basis for sorting mechanism of p62 in 
selective autophagy." J Biol Chem 283(33): 22847-22857. 
Kamiguti, A. S., L. Serrander, et al. (2005). "Expression and activity of NOX5 in the circulating 
malignant B cells of hairy cell leukemia." J Immunol 175(12): 8424-8430. 
Kampfer, S., M. Windegger, et al. (2001). "Protein kinase C isoforms involved in the transcriptional 
activation of cyclin D1 by transforming Ha-Ras." J Biol Chem 276(46): 42834-42842. 
Kaplowitz, N. and C. Ji (2006). "Unfolding new mechanisms of alcoholic liver disease in the 
endoplasmic reticulum." J Gastroenterol Hepatol 21 Suppl 3: S7-9. 
Kavanaugh, W. M. and L. T. Williams (1994). "An alternative to SH2 domains for binding 
tyrosine-phosphorylated proteins." Science 266(5192): 1862-1865. 
Kawanishi, S. and M. Murata (2006). "Mechanism of DNA damage induced by bromate differs 
from general types of oxidative stress." Toxicology 221(2-3): 172-178. 
70 
 
Kirkland, R. A., R. M. Adibhatla, et al. (2002). "Loss of cardiolipin and mitochondria during 
programmed neuronal death: evidence of a role for lipid peroxidation and autophagy." 
Neuroscience 115(2): 587-602. 
Kissova, I., M. Deffieu, et al. (2006). "Lipid oxidation and autophagy in yeast." Free Radic Biol 
Med 41(11): 1655-1661. 
Klionsky, D. J. and S. D. Emr (2000). "Autophagy as a regulated pathway of cellular degradation." 
Science 290(5497): 1717-1721. 
Komatsu, M., E. Kominami, et al. (2006). "Autophagy and neurodegeneration." Autophagy 2(4): 
315-317. 
Korsmeyer, S. J., M. C. Wei, et al. (2000). "Pro-apoptotic cascade activates BID, which 
oligomerizes BAK or BAX into pores that result in the release of cytochrome c." Cell Death 
Differ 7(12): 1166-1173. 
Kudo, N., N. Matsumori, et al. (1999). "Leptomycin B inactivates CRM1/exportin 1 by covalent 
modification at a cysteine residue in the central conserved region." Proc Natl Acad Sci U S 
A 96(16): 9112-9117. 
Kumar, B., S. Koul, et al. (2008). "Oxidative stress is inherent in prostate cancer cells and is 
required for aggressive phenotype." Cancer Res 68(6): 1777-1785. 
Laudanna, C., D. Mochly-Rosen, et al. (1998). "Evidence of zeta protein kinase C involvement in 
polymorphonuclear neutrophil integrin-dependent adhesion and chemotaxis." J Biol Chem 
273(46): 30306-30315. 
71 
 
Liu, X. J., C. Yang, et al. (2007). "Protein kinase C-zeta regulation of GLUT4 translocation through 
actin remodeling in CHO cells." J Mol Med 85(8): 851-861. 
Lum, J. J., D. E. Bauer, et al. (2005). "Growth factor regulation of autophagy and cell survival in 
the absence of apoptosis." Cell 120(2): 237-248. 
Madden, D. T., L. Egger, et al. (2007). "A calpain-like protease inhibits autophagic cell death." 
Autophagy 3(5): 519-522. 
Maiuri, M. C., A. Criollo, et al. (2007). "BH3-only proteins and BH3 mimetics induce autophagy 
by competitively disrupting the interaction between Beclin 1 and Bcl-2/Bcl-X(L)." 
Autophagy 3(4): 374-376. 
Maiuri, M. C., G. Le Toumelin, et al. (2007). "Functional and physical interaction between Bcl-
X(L) and a BH3-like domain in Beclin-1." EMBO J 26(10): 2527-2539. 
Mellor, H. and P. J. Parker (1998). "The extended protein kinase C superfamily." Biochem J 332 ( 
Pt 2): 281-292. 
Menini, S., L. Amadio, et al. (2006). "Deletion of p66Shc longevity gene protects against 
experimental diabetic glomerulopathy by preventing diabetes-induced oxidative stress." 
Diabetes 55(6): 1642-1650. 
Migliaccio, E., M. Giorgio, et al. (1999). "The p66shc adaptor protein controls oxidative stress 
response and life span in mammals." Nature 402(6759): 309-313. 
Migliaccio, E., S. Mele, et al. (1997). "Opposite effects of the p52shc/p46shc and p66shc splicing 
isoforms on the EGF receptor-MAP kinase-fos signalling pathway." EMBO J 16(4): 706-
716. 
72 
 
Napoli, C., I. Martin-Padura, et al. (2003). "Deletion of the p66Shc longevity gene reduces systemic 
and tissue oxidative stress, vascular cell apoptosis, and early atherogenesis in mice fed a 
high-fat diet." Proc Natl Acad Sci U S A 100(4): 2112-2116. 
Nemoto, S., C. A. Combs, et al. (2006). "The mammalian longevity-associated gene product p66shc 
regulates mitochondrial metabolism." J Biol Chem 281(15): 10555-10560. 
Patel, B. P., U. M. Rawal, et al. (2007). "Lipid peroxidation, total antioxidant status, and total thiol 
levels predict overall survival in patients with oral squamous cell carcinoma." Integr Cancer 
Ther 6(4): 365-372. 
Pattingre, S., A. Tassa, et al. (2005). "Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent 
autophagy." Cell 122(6): 927-939. 
Perander, M., G. Bjorkoy, et al. (2001). "Nuclear import and export signals enable rapid 
nucleocytoplasmic shuttling of the atypical protein kinase C lambda." J Biol Chem 276(16): 
13015-13024. 
Pinton, P., D. Ferrari, et al. (2001). "The Ca2+ concentration of the endoplasmic reticulum is a key 
determinant of ceramide-induced apoptosis: significance for the molecular mechanism of 
Bcl-2 action." EMBO J 20(11): 2690-2701. 
Pinton, P., A. Rimessi, et al. (2007). "Protein kinase C beta and prolyl isomerase 1 regulate 
mitochondrial effects of the life-span determinant p66Shc." Science 315(5812): 659-663. 
Pyo, J. O., M. H. Jang, et al. (2005). "Essential roles of Atg5 and FADD in autophagic cell death: 
dissection of autophagic cell death into vacuole formation and cell death." J Biol Chem 
280(21): 20722-20729. 
73 
 
Rimessi, A., R. Rizzuto, et al. (2007). "Differential recruitment of PKC isoforms in HeLa cells 
during redox stress." Cell Stress Chaperones 12(4): 291-298. 
Rizzuto, R., W. Carrington, et al. (1998). "Digital imaging microscopy of living cells." Trends Cell 
Biol 8(7): 288-292. 
Schafer, B., J. Quispe, et al. (2009). "Mitochondrial outer membrane proteins assist Bid in Bax-
mediated lipidic pore formation." Mol Biol Cell 20(8): 2276-2285. 
Scherz-Shouval, R., E. Shvets, et al. (2007). "Reactive oxygen species are essential for autophagy 
and specifically regulate the activity of Atg4." EMBO J 26(7): 1749-1760. 
Scorrano, L., M. Ashiya, et al. (2002). "A distinct pathway remodels mitochondrial cristae and 
mobilizes cytochrome c during apoptosis." Dev Cell 2(1): 55-67. 
Sekulic, A., C. C. Hudson, et al. (2000). "A direct linkage between the phosphoinositide 3-kinase-
AKT signaling pathway and the mammalian target of rapamycin in mitogen-stimulated and 
transformed cells." Cancer Res 60(13): 3504-3513. 
Shimizu, S., T. Kanaseki, et al. (2004). "Role of Bcl-2 family proteins in a non-apoptotic 
programmed cell death dependent on autophagy genes." Nat Cell Biol 6(12): 1221-1228. 
Smith, L. C. and J. L. Nordstrom (2000). "Advances in plasmid gene delivery and expression in 
skeletal muscle." Curr Opin Mol Ther 2(2): 150-154. 
Sou, Y. S., S. Waguri, et al. (2008). "The Atg8 conjugation system is indispensable for proper 
development of autophagic isolation membranes in mice." Mol Biol Cell 19(11): 4762-
4775. 
74 
 
Szatrowski, T. P. and C. F. Nathan (1991). "Production of large amounts of hydrogen peroxide by 
human tumor cells." Cancer Res 51(3): 794-798. 
Trachootham, D., W. Lu, et al. (2008). "Redox regulation of cell survival." Antioxid Redox Signal 
10(8): 1343-1374. 
Tsujimoto, Y., N. Ikegaki, et al. (1987). "Characterization of the protein product of bcl-2, the gene 
involved in human follicular lymphoma." Oncogene 2(1): 3-7. 
Uezumi, A., S. Fukada, et al. (2010). "Mesenchymal progenitors distinct from satellite cells 
contribute to ectopic fat cell formation in skeletal muscle." Nat Cell Biol 12(2): 143-152. 
Wagatsuma, A. (2007). "Adipogenic potential can be activated during muscle regeneration." Mol 
Cell Biochem 304(1-2): 25-33. 
Willis, S. N., L. Chen, et al. (2005). "Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not 
Bcl-2, until displaced by BH3-only proteins." Genes Dev 19(11): 1294-1305. 
Yannoni, Y. M., M. Gaestel, et al. (2004). "P66(ShcA) interacts with MAPKAP kinase 2 and 
regulates its activity." FEBS Lett 564(1-2): 205-211. 
Yousefi, S., R. Perozzo, et al. (2006). "Calpain-mediated cleavage of Atg5 switches autophagy to 
apoptosis." Nat Cell Biol 8(10): 1124-1132. 
Zaccagnini, G., F. Martelli, et al. (2007). "p66(ShcA) and oxidative stress modulate myogenic 
differentiation and skeletal muscle regeneration after hind limb ischemia." J Biol Chem 
282(43): 31453-31459. 
75 
 
Zhou, Y., J. A. McEarchern, et al. (2003). "Dendritic cells efficiently acquire and present antigen 
derived from lung cancer cells and induce antigen-specific T-cell responses." Cancer 
Immunol Immunother 52(7): 413-422. 
 
 
 
